| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.722 | 0.005 | 0.76 | Vasodilator, peripheral | 0.76 0.004 DBMET01486 0.76 0.004 DBMET01487 0.76 0.004 DBMET01488 0.76 0.004 DBMET01489 0.76 0.004 DBMET01490 0.573 0.019 DBMET01491 | DBMET01490 | |
| 0.653 | 0.012 | 0.717 | Cholesterol antagonist | 0.717 0.007 DBMET01486 0.717 0.007 DBMET01487 0.717 0.007 DBMET01488 0.717 0.007 DBMET01489 0.717 0.007 DBMET01490 0.635 0.014 DBMET01491 | DBMET01490 | |
| 0.577 | 0.007 | 0.577 | Vasodilator | 0.56 0.008 DBMET01486 0.56 0.008 DBMET01487 0.56 0.008 DBMET01488 0.56 0.008 DBMET01489 0.56 0.008 DBMET01490 0.49 0.013 DBMET01491 | ||
| 0.582 | 0.014 | 0.582 | 5 Hydroxytryptamine release inhibitor | 0.544 0.021 DBMET01486 0.544 0.021 DBMET01487 0.544 0.021 DBMET01488 0.544 0.021 DBMET01489 0.544 0.021 DBMET01490 0.544 0.021 DBMET01491 | ||
| 0.549 | 0.016 | 0.549 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.465 0.052 DBMET01486 0.465 0.052 DBMET01487 0.465 0.052 DBMET01488 0.465 0.052 DBMET01489 0.465 0.052 DBMET01490 0.51 0.029 DBMET01491 | ||
| 0.534 | 0.006 | 0.534 | P-glycoprotein inhibitor | 0.485 0.009 DBMET01486 0.485 0.009 DBMET01487 0.485 0.009 DBMET01488 0.485 0.009 DBMET01489 0.485 0.009 DBMET01490 0.283 0.032 DBMET01491 | ||
| 0.536 | 0.019 | 0.564 | Histamine release inhibitor | 0.564 0.014 DBMET01486 0.564 0.014 DBMET01487 0.564 0.014 DBMET01488 0.564 0.014 DBMET01489 0.564 0.014 DBMET01490 0.528 0.021 DBMET01491 | DBMET01490 | |
| 0.487 | 0.029 | 0.585 | GABA C receptor rho-3 antagonist | 0.414 0.056 DBMET01486 0.414 0.056 DBMET01487 0.414 0.056 DBMET01488 0.414 0.056 DBMET01489 0.414 0.056 DBMET01490 0.585 0.009 DBMET01491 | DBMET01491 | |
| 0.475 | 0.027 | 0.493 | Spasmolytic | 0.493 0.024 DBMET01486 0.493 0.024 DBMET01487 0.493 0.024 DBMET01488 0.493 0.024 DBMET01489 0.493 0.024 DBMET01490 0.328 0.06 DBMET01491 | DBMET01490 | |
| 0.453 | 0.01 | 0.48 | Calcium channel activator | 0.47 0.008 DBMET01486 0.47 0.008 DBMET01487 0.47 0.008 DBMET01488 0.47 0.008 DBMET01489 0.47 0.008 DBMET01490 0.48 0.007 DBMET01491 | DBMET01491 | |
| 0.433 | 0.007 | 0.584 | NOS3 expression enhancer | 0.492 0.005 DBMET01486 0.492 0.005 DBMET01487 0.492 0.005 DBMET01488 0.492 0.005 DBMET01489 0.492 0.005 DBMET01490 0.584 0.004 DBMET01491 | DBMET01491 | |
| 0.499 | 0.088 | 0.828 | Antiinflammatory | 0.621 0.048 DBMET01486 0.621 0.048 DBMET01487 0.621 0.048 DBMET01488 0.621 0.048 DBMET01489 0.621 0.048 DBMET01490 0.828 0.012 DBMET01491 | DBMET01491 | |
| 0.437 | 0.026 | 0.486 | Vasodilator, coronary | 0.486 0.017 DBMET01486 0.486 0.017 DBMET01487 0.486 0.017 DBMET01488 0.486 0.017 DBMET01489 0.486 0.017 DBMET01490 0.454 0.023 DBMET01491 | DBMET01490 | |
| 0.389 | 0.025 | 0.389 | Antimitotic | 0.349 0.032 DBMET01486 0.349 0.032 DBMET01487 0.349 0.032 DBMET01488 0.349 0.032 DBMET01489 0.349 0.032 DBMET01490 0.197 0.086 DBMET01491 | ||
| 0.41 | 0.047 | 0.505 | Antithrombotic | 0.505 0.028 DBMET01486 0.505 0.028 DBMET01487 0.505 0.028 DBMET01488 0.505 0.028 DBMET01489 0.505 0.028 DBMET01490 0.45 0.038 DBMET01491 | DBMET01490 | |
| 0.382 | 0.023 | 0.574 | Peroxidase inhibitor | 0.374 0.024 DBMET01486 0.374 0.024 DBMET01487 0.374 0.024 DBMET01488 0.374 0.024 DBMET01489 0.374 0.024 DBMET01490 0.574 0.005 DBMET01491 | DBMET01491 | |
| 0.355 | 0.011 | 0.849 | Alpha-N-acetylglucosaminidase inhibitor | 0.435 0.007 DBMET01486 0.435 0.007 DBMET01487 0.435 0.007 DBMET01488 0.435 0.007 DBMET01489 0.435 0.007 DBMET01490 0.849 0.002 DBMET01491 | DBMET01491 | |
| 0.345 | 0.005 | 0.399 | Nitric-oxide synthase stimulant | 0.38 0.004 DBMET01486 0.38 0.004 DBMET01487 0.38 0.004 DBMET01488 0.38 0.004 DBMET01489 0.38 0.004 DBMET01490 0.399 0.004 DBMET01491 | DBMET01491 | |
| 0.354 | 0.025 | 0.382 | Cyclic AMP phosphodiesterase inhibitor | 0.382 0.019 DBMET01486 0.382 0.019 DBMET01487 0.382 0.019 DBMET01488 0.382 0.019 DBMET01489 0.382 0.019 DBMET01490 0.372 0.021 DBMET01491 | DBMET01490 | |
| 0.327 | 0.007 | 0.327 | 3C-like protease (Human coronavirus) inhibitor | 0.273 0.019 DBMET01486 0.273 0.019 DBMET01487 0.273 0.019 DBMET01488 0.273 0.019 DBMET01489 0.273 0.019 DBMET01490 0.213 0.045 DBMET01491 | ||
| 0.42 | 0.104 | 0.708 | Apoptosis agonist | 0.498 0.075 DBMET01486 0.498 0.075 DBMET01487 0.498 0.075 DBMET01488 0.498 0.075 DBMET01489 0.498 0.075 DBMET01490 0.708 0.029 DBMET01491 | DBMET01491 | |
| 0.351 | 0.037 | 0.743 | Hypoglycemic | 0.488 0.016 DBMET01486 0.488 0.016 DBMET01487 0.488 0.016 DBMET01488 0.488 0.016 DBMET01489 0.488 0.016 DBMET01490 0.743 0.004 DBMET01491 | DBMET01491 | |
| 0.4 | 0.091 | 0.902 | Cyclophilin D inhibitor | 0.608 0.026 DBMET01486 0.608 0.026 DBMET01487 0.608 0.026 DBMET01488 0.608 0.026 DBMET01489 0.608 0.026 DBMET01490 0.902 0.005 DBMET01491 | DBMET01491 | |
| 0.377 | 0.069 | 0.479 | Transcription factor NF kappa B inhibitor | 0.479 0.047 DBMET01486 0.479 0.047 DBMET01487 0.479 0.047 DBMET01488 0.479 0.047 DBMET01489 0.479 0.047 DBMET01490 0.449 0.053 DBMET01491 | DBMET01490 | |
| 0.349 | 0.041 | 0.384 | DNA damaging | 0.384 0.032 DBMET01486 0.384 0.032 DBMET01487 0.384 0.032 DBMET01488 0.384 0.032 DBMET01489 0.384 0.032 DBMET01490 0.347 0.042 DBMET01491 | DBMET01490 | |
| 0.329 | 0.025 | 0.467 | Platelet adhesion inhibitor | 0.364 0.017 DBMET01486 0.364 0.017 DBMET01487 0.364 0.017 DBMET01488 0.364 0.017 DBMET01489 0.364 0.017 DBMET01490 0.467 0.007 DBMET01491 | DBMET01491 | |
| 0.338 | 0.039 | 0.494 | Superoxide dismutase inhibitor | 0.323 0.043 DBMET01486 0.323 0.043 DBMET01487 0.323 0.043 DBMET01488 0.323 0.043 DBMET01489 0.323 0.043 DBMET01490 0.494 0.013 DBMET01491 | DBMET01491 | |
| 0.321 | 0.035 | 0.482 | 5 Hydroxytryptamine uptake stimulant | 0.269 0.064 DBMET01486 0.269 0.064 DBMET01487 0.269 0.064 DBMET01488 0.269 0.064 DBMET01489 0.269 0.064 DBMET01490 0.482 0.005 DBMET01491 | DBMET01491 | |
| 0.319 | 0.038 | 0.466 | DNA synthesis inhibitor | 0.382 0.024 DBMET01486 0.382 0.024 DBMET01487 0.382 0.024 DBMET01488 0.382 0.024 DBMET01489 0.382 0.024 DBMET01490 0.466 0.016 DBMET01491 | DBMET01491 | |
| 0.359 | 0.082 | 0.61 | Immunosuppressant | 0.435 0.051 DBMET01486 0.435 0.051 DBMET01487 0.435 0.051 DBMET01488 0.435 0.051 DBMET01489 0.435 0.051 DBMET01490 0.61 0.012 DBMET01491 | DBMET01491 | |
| 0.392 | 0.116 | 0.762 | Caspase 9 stimulant | 0.456 0.08 DBMET01486 0.456 0.08 DBMET01487 0.456 0.08 DBMET01488 0.456 0.08 DBMET01489 0.456 0.08 DBMET01490 0.762 0.016 DBMET01491 | DBMET01491 | |
| 0.297 | 0.029 | 0.341 | Non-steroidal antiinflammatory agent | 0.341 0.021 DBMET01486 0.341 0.021 DBMET01487 0.341 0.021 DBMET01488 0.341 0.021 DBMET01489 0.341 0.021 DBMET01490 0.272 0.035 DBMET01491 | DBMET01490 | |
| 0.247 | 0.005 | 0.247 | Histone deacetylase stimulant | 0.233 0.005 DBMET01486 0.233 0.005 DBMET01487 0.233 0.005 DBMET01488 0.233 0.005 DBMET01489 0.233 0.005 DBMET01490 0.13 0.014 DBMET01491 | ||
| 0.247 | 0.005 | 0.247 | Histone deacetylase SIRT1 stimulant | 0.233 0.005 DBMET01486 0.233 0.005 DBMET01487 0.233 0.005 DBMET01488 0.233 0.005 DBMET01489 0.233 0.005 DBMET01490 0.13 0.014 DBMET01491 | ||
| 0.248 | 0.008 | 0.319 | Porphobilinogen synthase inhibitor | 0.234 0.009 DBMET01486 0.234 0.009 DBMET01487 0.234 0.009 DBMET01488 0.234 0.009 DBMET01489 0.234 0.009 DBMET01490 0.319 0.005 DBMET01491 | DBMET01491 | |
| 0.258 | 0.024 | 0.258 | MAP kinase kinase 3 inhibitor | 0.222 0.07 DBMET01486 0.222 0.07 DBMET01487 0.222 0.07 DBMET01488 0.222 0.07 DBMET01489 0.222 0.07 DBMET01490 | ||
| 0.339 | 0.108 | 0.476 | Antibacterial | 0.444 0.059 DBMET01486 0.444 0.059 DBMET01487 0.444 0.059 DBMET01488 0.444 0.059 DBMET01489 0.444 0.059 DBMET01490 0.476 0.048 DBMET01491 | DBMET01491 | |
| 0.233 | 0.009 | 0.233 | Protein kinase C gamma inhibitor | 0.218 0.011 DBMET01486 0.218 0.011 DBMET01487 0.218 0.011 DBMET01488 0.218 0.011 DBMET01489 0.218 0.011 DBMET01490 0.158 0.027 DBMET01491 | ||
| 0.264 | 0.042 | 0.446 | RNA-directed DNA polymerase inhibitor | 0.275 0.038 DBMET01486 0.275 0.038 DBMET01487 0.275 0.038 DBMET01488 0.275 0.038 DBMET01489 0.275 0.038 DBMET01490 0.446 0.014 DBMET01491 | DBMET01491 | |
| 0.223 | 0.005 | 0.866 | Alcohol oxidase inhibitor | 0.337 0.004 DBMET01486 0.337 0.004 DBMET01487 0.337 0.004 DBMET01488 0.337 0.004 DBMET01489 0.337 0.004 DBMET01490 0.866 0.002 DBMET01491 | DBMET01491 | |
| 0.222 | 0.005 | 0.222 | CYP2A6 inhibitor | 0.144 0.018 DBMET01486 0.144 0.018 DBMET01487 0.144 0.018 DBMET01488 0.144 0.018 DBMET01489 0.144 0.018 DBMET01490 0.109 0.032 DBMET01491 | ||
| 0.26 | 0.046 | 0.511 | Anesthetic general | 0.338 0.026 DBMET01486 0.338 0.026 DBMET01487 0.338 0.026 DBMET01488 0.338 0.026 DBMET01489 0.338 0.026 DBMET01490 0.511 0.007 DBMET01491 | DBMET01491 | |
| 0.223 | 0.011 | 0.223 | Protein kinase A inhibitor | 0.172 0.019 DBMET01486 0.172 0.019 DBMET01487 0.172 0.019 DBMET01488 0.172 0.019 DBMET01489 0.172 0.019 DBMET01490 | ||
| 0.302 | 0.091 | 0.302 | Angiogenesis inhibitor | 0.266 0.111 DBMET01486 0.266 0.111 DBMET01487 0.266 0.111 DBMET01488 0.266 0.111 DBMET01489 0.266 0.111 DBMET01490 | ||
| 0.227 | 0.021 | 0.256 | Cholesterol synthesis inhibitor | 0.251 0.018 DBMET01486 0.251 0.018 DBMET01487 0.251 0.018 DBMET01488 0.251 0.018 DBMET01489 0.251 0.018 DBMET01490 0.256 0.017 DBMET01491 | DBMET01491 | |
| 0.218 | 0.013 | 0.388 | Adenylate kinase inhibitor | 0.252 0.01 DBMET01486 0.252 0.01 DBMET01487 0.252 0.01 DBMET01488 0.252 0.01 DBMET01489 0.252 0.01 DBMET01490 0.388 0.004 DBMET01491 | DBMET01491 | |
| 0.209 | 0.007 | 0.209 | Protein kinase C delta inhibitor | 0.176 0.013 DBMET01486 0.176 0.013 DBMET01487 0.176 0.013 DBMET01488 0.176 0.013 DBMET01489 0.176 0.013 DBMET01490 | ||
| 0.209 | 0.01 | 0.423 | Selectin antagonist | 0.293 0.006 DBMET01486 0.293 0.006 DBMET01487 0.293 0.006 DBMET01488 0.293 0.006 DBMET01489 0.293 0.006 DBMET01490 0.423 0.003 DBMET01491 | DBMET01491 | |
| 0.202 | 0.005 | 0.202 | DNA gyrase inhibitor | 0.168 0.006 DBMET01486 0.168 0.006 DBMET01487 0.168 0.006 DBMET01488 0.168 0.006 DBMET01489 0.168 0.006 DBMET01490 | ||
| 0.265 | 0.068 | 0.436 | Tumour necrosis factor alpha release inhibitor | 0.291 0.057 DBMET01486 0.291 0.057 DBMET01487 0.291 0.057 DBMET01488 0.291 0.057 DBMET01489 0.291 0.057 DBMET01490 0.436 0.021 DBMET01491 | DBMET01491 | |
| 0.202 | 0.008 | 0.226 | Keratolytic | 0.226 0.006 DBMET01486 0.226 0.006 DBMET01487 0.226 0.006 DBMET01488 0.226 0.006 DBMET01489 0.226 0.006 DBMET01490 0.192 0.009 DBMET01491 | DBMET01490 | |
| 0.226 | 0.036 | 0.253 | Cytidine deaminase inhibitor | 0.214 0.041 DBMET01486 0.214 0.041 DBMET01487 0.214 0.041 DBMET01488 0.214 0.041 DBMET01489 0.214 0.041 DBMET01490 0.253 0.028 DBMET01491 | DBMET01491 | |
| 0.203 | 0.02 | 0.559 | GABA C receptor agonist | 0.199 0.02 DBMET01486 0.199 0.02 DBMET01487 0.199 0.02 DBMET01488 0.199 0.02 DBMET01489 0.199 0.02 DBMET01490 0.559 0.003 DBMET01491 | DBMET01491 | |
| 0.199 | 0.017 | 0.199 | Beta amyloid protein antagonist | 0.189 0.02 DBMET01486 0.189 0.02 DBMET01487 0.189 0.02 DBMET01488 0.189 0.02 DBMET01489 0.189 0.02 DBMET01490 0.176 0.026 DBMET01491 | ||
| 0.248 | 0.071 | 0.73 | Angiogenesis stimulant | 0.358 0.03 DBMET01486 0.358 0.03 DBMET01487 0.358 0.03 DBMET01488 0.358 0.03 DBMET01489 0.358 0.03 DBMET01490 0.73 0.004 DBMET01491 | DBMET01491 | |
| 0.203 | 0.027 | 0.243 | GABA C receptor rho-2 antagonist | 0.165 0.055 DBMET01486 0.165 0.055 DBMET01487 0.165 0.055 DBMET01488 0.165 0.055 DBMET01489 0.165 0.055 DBMET01490 0.243 0.013 DBMET01491 | DBMET01491 | |
| 0.191 | 0.018 | 0.282 | Adenylate cyclase stimulant | 0.217 0.008 DBMET01486 0.217 0.008 DBMET01487 0.217 0.008 DBMET01488 0.217 0.008 DBMET01489 0.217 0.008 DBMET01490 0.282 0.003 DBMET01491 | DBMET01491 | |
| 0.178 | 0.005 | 0.178 | Protein kinase C eta inhibitor | 0.159 0.007 DBMET01486 0.159 0.007 DBMET01487 0.159 0.007 DBMET01488 0.159 0.007 DBMET01489 0.159 0.007 DBMET01490 0.097 0.018 DBMET01491 | ||
| 0.32 | 0.15 | 0.456 | Alpha-glucosidase inhibitor | 0.456 0.094 DBMET01486 0.456 0.094 DBMET01487 0.456 0.094 DBMET01488 0.456 0.094 DBMET01489 0.456 0.094 DBMET01490 0.398 0.116 DBMET01491 | DBMET01490 | |
| 0.188 | 0.02 | 0.494 | UDP-glucose 4-epimerase inhibitor | 0.296 0.01 DBMET01486 0.296 0.01 DBMET01487 0.296 0.01 DBMET01488 0.296 0.01 DBMET01489 0.296 0.01 DBMET01490 0.494 0.003 DBMET01491 | DBMET01491 | |
| 0.202 | 0.035 | 0.301 | ATPase inhibitor | 0.237 0.017 DBMET01486 0.237 0.017 DBMET01487 0.237 0.017 DBMET01488 0.237 0.017 DBMET01489 0.237 0.017 DBMET01490 0.301 0.006 DBMET01491 | DBMET01491 | |
| 0.226 | 0.064 | 0.226 | Platelet aggregation inhibitor | 0.178 0.099 DBMET01486 0.178 0.099 DBMET01487 0.178 0.099 DBMET01488 0.178 0.099 DBMET01489 0.178 0.099 DBMET01490 | ||
| 0.177 | 0.015 | 0.177 | Acetylcholine nicotinic antagonist | 0.13 0.027 DBMET01486 0.13 0.027 DBMET01487 0.13 0.027 DBMET01488 0.13 0.027 DBMET01489 0.13 0.027 DBMET01490 0.077 0.058 DBMET01491 | ||
| 0.179 | 0.018 | 0.245 | Photosensitizer | 0.2 0.013 DBMET01486 0.2 0.013 DBMET01487 0.2 0.013 DBMET01488 0.2 0.013 DBMET01489 0.2 0.013 DBMET01490 0.245 0.006 DBMET01491 | DBMET01491 | |
| 0.218 | 0.057 | 0.259 | Insulin sensitizer | 0.241 0.039 DBMET01486 0.241 0.039 DBMET01487 0.241 0.039 DBMET01488 0.241 0.039 DBMET01489 0.241 0.039 DBMET01490 0.259 0.029 DBMET01491 | DBMET01491 | |
| 0.2 | 0.041 | 0.351 | Interferon gamma antagonist | 0.274 0.024 DBMET01486 0.274 0.024 DBMET01487 0.274 0.024 DBMET01488 0.274 0.024 DBMET01489 0.274 0.024 DBMET01490 0.351 0.014 DBMET01491 | DBMET01491 | |
| 0.176 | 0.02 | 0.404 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.182 0.019 DBMET01486 0.182 0.019 DBMET01487 0.182 0.019 DBMET01488 0.182 0.019 DBMET01489 0.182 0.019 DBMET01490 0.404 0.004 DBMET01491 | DBMET01491 | |
| 0.223 | 0.069 | 0.305 | Psychostimulant | 0.22 0.07 DBMET01486 0.22 0.07 DBMET01487 0.22 0.07 DBMET01488 0.22 0.07 DBMET01489 0.22 0.07 DBMET01490 0.305 0.041 DBMET01491 | DBMET01491 | |
| 0.168 | 0.015 | 0.222 | Ca2+-transporting ATPase inhibitor | 0.171 0.012 DBMET01486 0.171 0.012 DBMET01487 0.171 0.012 DBMET01488 0.171 0.012 DBMET01489 0.171 0.012 DBMET01490 0.222 0.002 DBMET01491 | DBMET01491 | |
| 0.16 | 0.008 | 0.181 | Phosphodiesterase 6D inhibitor | 0.181 0.005 DBMET01486 0.181 0.005 DBMET01487 0.181 0.005 DBMET01488 0.181 0.005 DBMET01489 0.181 0.005 DBMET01490 0.147 0.01 DBMET01491 | DBMET01490 | |
| 0.166 | 0.014 | 0.191 | Toll-Like receptor 4 antagonist | 0.171 0.012 DBMET01486 0.171 0.012 DBMET01487 0.171 0.012 DBMET01488 0.171 0.012 DBMET01489 0.171 0.012 DBMET01490 0.191 0.008 DBMET01491 | DBMET01491 | |
| 0.174 | 0.027 | 0.245 | Microtubule formation inhibitor | 0.208 0.018 DBMET01486 0.208 0.018 DBMET01487 0.208 0.018 DBMET01488 0.208 0.018 DBMET01489 0.208 0.018 DBMET01490 0.245 0.01 DBMET01491 | DBMET01491 | |
| 0.158 | 0.012 | 0.158 | Acetylcholine release stimulant | 0.139 0.024 DBMET01486 0.139 0.024 DBMET01487 0.139 0.024 DBMET01488 0.139 0.024 DBMET01489 0.139 0.024 DBMET01490 0.15 0.016 DBMET01491 | ||
| 0.189 | 0.044 | 0.253 | Arachidonic acid antagonist | 0.2 0.033 DBMET01486 0.2 0.033 DBMET01487 0.2 0.033 DBMET01488 0.2 0.033 DBMET01489 0.2 0.033 DBMET01490 0.253 0.005 DBMET01491 | DBMET01491 | |
| 0.182 | 0.038 | 0.269 | Cell wall synthesis inhibitor | 0.208 0.027 DBMET01486 0.208 0.027 DBMET01487 0.208 0.027 DBMET01488 0.208 0.027 DBMET01489 0.208 0.027 DBMET01490 0.269 0.013 DBMET01491 | DBMET01491 | |
| 0.179 | 0.035 | 0.179 | MAP kinase 3 inhibitor | 0.171 0.042 DBMET01486 0.171 0.042 DBMET01487 0.171 0.042 DBMET01488 0.171 0.042 DBMET01489 0.171 0.042 DBMET01490 0.159 0.055 DBMET01491 | ||
| 0.158 | 0.016 | 0.196 | Electrolyte absorption antagonist | 0.134 0.027 DBMET01486 0.134 0.027 DBMET01487 0.134 0.027 DBMET01488 0.134 0.027 DBMET01489 0.134 0.027 DBMET01490 0.196 0.009 DBMET01491 | DBMET01491 | |
| 0.149 | 0.008 | 0.149 | Nicotinic alpha4beta2 receptor antagonist | 0.117 0.019 DBMET01486 0.117 0.019 DBMET01487 0.117 0.019 DBMET01488 0.117 0.019 DBMET01489 0.117 0.019 DBMET01490 0.097 0.034 DBMET01491 | ||
| 0.156 | 0.015 | 0.166 | Thioredoxin inhibitor | 0.161 0.014 DBMET01486 0.161 0.014 DBMET01487 0.161 0.014 DBMET01488 0.161 0.014 DBMET01489 0.161 0.014 DBMET01490 0.166 0.013 DBMET01491 | DBMET01491 | |
| 0.145 | 0.007 | 0.145 | Protein kinase C epsilon inhibitor | 0.094 0.014 DBMET01486 0.094 0.014 DBMET01487 0.094 0.014 DBMET01488 0.094 0.014 DBMET01489 0.094 0.014 DBMET01490 | ||
| 0.166 | 0.03 | 0.166 | Interleukin 1b antagonist | 0.137 0.049 DBMET01486 0.137 0.049 DBMET01487 0.137 0.049 DBMET01488 0.137 0.049 DBMET01489 0.137 0.049 DBMET01490 | ||
| 0.185 | 0.048 | 0.351 | Melanin inhibitor | 0.267 0.026 DBMET01486 0.267 0.026 DBMET01487 0.267 0.026 DBMET01488 0.267 0.026 DBMET01489 0.267 0.026 DBMET01490 0.351 0.016 DBMET01491 | DBMET01491 | |
| 0.243 | 0.107 | 0.321 | Hypoxia-inducible factor 1 alpha inhibitor | 0.273 0.081 DBMET01486 0.273 0.081 DBMET01487 0.273 0.081 DBMET01488 0.273 0.081 DBMET01489 0.273 0.081 DBMET01490 0.321 0.056 DBMET01491 | DBMET01491 | |
| 0.284 | 0.151 | 0.284 | MAP kinase kinase 6 inhibitor | 0.233 0.214 DBMET01486 0.233 0.214 DBMET01487 0.233 0.214 DBMET01488 0.233 0.214 DBMET01489 0.233 0.214 DBMET01490 | ||
| 0.169 | 0.037 | 0.307 | Aldehyde dehydrogenase inhibitor | 0.205 0.026 DBMET01486 0.205 0.026 DBMET01487 0.205 0.026 DBMET01488 0.205 0.026 DBMET01489 0.205 0.026 DBMET01490 0.307 0.011 DBMET01491 | DBMET01491 | |
| 0.136 | 0.005 | 0.168 | Aconitate hydratase inhibitor | 0.113 0.006 DBMET01486 0.113 0.006 DBMET01487 0.113 0.006 DBMET01488 0.113 0.006 DBMET01489 0.113 0.006 DBMET01490 0.168 0.004 DBMET01491 | DBMET01491 | |
| 0.161 | 0.03 | 0.208 | Xanthine oxidase inhibitor | 0.208 0.018 DBMET01486 0.208 0.018 DBMET01487 0.208 0.018 DBMET01488 0.208 0.018 DBMET01489 0.208 0.018 DBMET01490 0.175 0.026 DBMET01491 | DBMET01490 | |
| 0.204 | 0.073 | 0.339 | Neurotrophic factor enhancer | 0.236 0.047 DBMET01486 0.236 0.047 DBMET01487 0.236 0.047 DBMET01488 0.236 0.047 DBMET01489 0.236 0.047 DBMET01490 0.339 0.01 DBMET01491 | DBMET01491 | |
| 0.254 | 0.124 | 0.62 | Apoptosis antagonist | 0.343 0.059 DBMET01486 0.343 0.059 DBMET01487 0.343 0.059 DBMET01488 0.343 0.059 DBMET01489 0.343 0.059 DBMET01490 0.62 0.008 DBMET01491 | DBMET01491 | |
| 0.165 | 0.037 | 0.228 | Cyclooxygenase 3 inhibitor | 0.183 0.026 DBMET01486 0.183 0.026 DBMET01487 0.183 0.026 DBMET01488 0.183 0.026 DBMET01489 0.183 0.026 DBMET01490 0.228 0.012 DBMET01491 | DBMET01491 | |
| 0.162 | 0.036 | 0.369 | Cystathionine beta-synthase inhibitor | 0.219 0.02 DBMET01486 0.219 0.02 DBMET01487 0.219 0.02 DBMET01488 0.219 0.02 DBMET01489 0.219 0.02 DBMET01490 0.369 0.006 DBMET01491 | DBMET01491 | |
| 0.16 | 0.034 | 0.387 | Ferrochelatase inhibitor | 0.112 0.06 DBMET01486 0.112 0.06 DBMET01487 0.112 0.06 DBMET01488 0.112 0.06 DBMET01489 0.112 0.06 DBMET01490 0.387 0.004 DBMET01491 | DBMET01491 | |
| 0.171 | 0.046 | 0.171 | Interleukin 1 antagonist | 0.136 0.069 DBMET01486 0.136 0.069 DBMET01487 0.136 0.069 DBMET01488 0.136 0.069 DBMET01489 0.136 0.069 DBMET01490 | ||
| 0.136 | 0.014 | 0.136 | Neuronal nicotinic receptor antagonist | 0.093 0.027 DBMET01486 0.093 0.027 DBMET01487 0.093 0.027 DBMET01488 0.093 0.027 DBMET01489 0.093 0.027 DBMET01490 | ||
| 0.132 | 0.012 | 0.315 | Biliverdin reductase inhibitor | 0.146 0.01 DBMET01486 0.146 0.01 DBMET01487 0.146 0.01 DBMET01488 0.146 0.01 DBMET01489 0.146 0.01 DBMET01490 0.315 0.003 DBMET01491 | DBMET01491 | |
| 0.183 | 0.064 | 0.339 | Succinate dehydrogenase inhibitor | 0.176 0.073 DBMET01486 0.176 0.073 DBMET01487 0.176 0.073 DBMET01488 0.176 0.073 DBMET01489 0.176 0.073 DBMET01490 0.339 0.006 DBMET01491 | DBMET01491 | |
| 0.129 | 0.01 | 0.296 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.155 0.008 DBMET01486 0.155 0.008 DBMET01487 0.155 0.008 DBMET01488 0.155 0.008 DBMET01489 0.155 0.008 DBMET01490 0.296 0.004 DBMET01491 | DBMET01491 | |
| 0.207 | 0.089 | 0.455 | Hypolipemic | 0.261 0.063 DBMET01486 0.261 0.063 DBMET01487 0.261 0.063 DBMET01488 0.261 0.063 DBMET01489 0.261 0.063 DBMET01490 0.455 0.017 DBMET01491 | DBMET01491 | |
| 0.146 | 0.03 | 0.176 | Mediator release inhibitor | 0.176 0.02 DBMET01486 0.176 0.02 DBMET01487 0.176 0.02 DBMET01488 0.176 0.02 DBMET01489 0.176 0.02 DBMET01490 0.142 0.033 DBMET01491 | DBMET01490 | |
| 0.134 | 0.019 | 0.201 | Lanosterol 14 alpha demethylase inhibitor | 0.142 0.015 DBMET01486 0.142 0.015 DBMET01487 0.142 0.015 DBMET01488 0.142 0.015 DBMET01489 0.142 0.015 DBMET01490 0.201 0.004 DBMET01491 | DBMET01491 | |
| 0.138 | 0.024 | 0.54 | Triose-phosphate isomerase inhibitor | 0.188 0.012 DBMET01486 0.188 0.012 DBMET01487 0.188 0.012 DBMET01488 0.188 0.012 DBMET01489 0.188 0.012 DBMET01490 0.54 0.002 DBMET01491 | DBMET01491 | |
| 0.169 | 0.056 | 0.335 | Protein kinase stimulant | 0.232 0.031 DBMET01486 0.232 0.031 DBMET01487 0.232 0.031 DBMET01488 0.232 0.031 DBMET01489 0.232 0.031 DBMET01490 0.335 0.013 DBMET01491 | DBMET01491 | |
| 0.135 | 0.022 | 0.528 | NADH dehydrogenase inhibitor | 0.187 0.012 DBMET01486 0.187 0.012 DBMET01487 0.187 0.012 DBMET01488 0.187 0.012 DBMET01489 0.187 0.012 DBMET01490 0.528 0.003 DBMET01491 | DBMET01491 | |
| 0.146 | 0.034 | 0.156 | TRPA1 agonist | 0.14 0.038 DBMET01486 0.14 0.038 DBMET01487 0.14 0.038 DBMET01488 0.14 0.038 DBMET01489 0.14 0.038 DBMET01490 0.156 0.027 DBMET01491 | DBMET01491 | |
| 0.134 | 0.021 | 0.4 | Phosphofructokinase-1 inhibitor | 0.192 0.012 DBMET01486 0.192 0.012 DBMET01487 0.192 0.012 DBMET01488 0.192 0.012 DBMET01489 0.192 0.012 DBMET01490 0.4 0.003 DBMET01491 | DBMET01491 | |
| 0.123 | 0.011 | 0.134 | Xanthine dehydrogenase inhibitor | 0.134 0.009 DBMET01486 0.134 0.009 DBMET01487 0.134 0.009 DBMET01488 0.134 0.009 DBMET01489 0.134 0.009 DBMET01490 0.071 0.031 DBMET01491 | DBMET01490 | |
| 0.186 | 0.074 | 0.567 | Hepatoprotectant | 0.275 0.037 DBMET01486 0.275 0.037 DBMET01487 0.275 0.037 DBMET01488 0.275 0.037 DBMET01489 0.275 0.037 DBMET01490 0.567 0.005 DBMET01491 | DBMET01491 | |
| 0.127 | 0.016 | 0.273 | Phenylalanine 4-hydroxylase inhibitor | 0.127 0.016 DBMET01486 0.127 0.016 DBMET01487 0.127 0.016 DBMET01488 0.127 0.016 DBMET01489 0.127 0.016 DBMET01490 0.273 0.004 DBMET01491 | DBMET01491 | |
| 0.117 | 0.008 | 0.117 | Protein kinase C beta inhibitor | 0.114 0.009 DBMET01486 0.114 0.009 DBMET01487 0.114 0.009 DBMET01488 0.114 0.009 DBMET01489 0.114 0.009 DBMET01490 0.101 0.013 DBMET01491 | ||
| 0.136 | 0.028 | 0.218 | GABA C receptor rho-1 antagonist | 0.109 0.051 DBMET01486 0.109 0.051 DBMET01487 0.109 0.051 DBMET01488 0.109 0.051 DBMET01489 0.109 0.051 DBMET01490 0.218 0.006 DBMET01491 | DBMET01491 | |
| 0.113 | 0.005 | 0.113 | Nicotinic alpha3beta2 receptor antagonist | 0.095 0.009 DBMET01486 0.095 0.009 DBMET01487 0.095 0.009 DBMET01488 0.095 0.009 DBMET01489 0.095 0.009 DBMET01490 0.079 0.013 DBMET01491 | ||
| 0.135 | 0.027 | 0.179 | Anabolic | 0.144 0.022 DBMET01486 0.144 0.022 DBMET01487 0.144 0.022 DBMET01488 0.144 0.022 DBMET01489 0.144 0.022 DBMET01490 0.179 0.007 DBMET01491 | DBMET01491 | |
| 0.131 | 0.024 | 0.131 | ABCA1 expression enhancer | 0.117 0.033 DBMET01486 0.117 0.033 DBMET01487 0.117 0.033 DBMET01488 0.117 0.033 DBMET01489 0.117 0.033 DBMET01490 | ||
| 0.162 | 0.055 | 0.322 | Mannose-6-phosphate isomerase inhibitor | 0.192 0.035 DBMET01486 0.192 0.035 DBMET01487 0.192 0.035 DBMET01488 0.192 0.035 DBMET01489 0.192 0.035 DBMET01490 0.322 0.004 DBMET01491 | DBMET01491 | |
| 0.111 | 0.005 | 0.111 | Acetyl-CoA transferase 2 inhibitor | 0.101 0.005 DBMET01486 0.101 0.005 DBMET01487 0.101 0.005 DBMET01488 0.101 0.005 DBMET01489 0.101 0.005 DBMET01490 0.07 0.017 DBMET01491 | ||
| 0.137 | 0.032 | 0.137 | Protein kinase C mu inhibitor | 0.124 0.039 DBMET01486 0.124 0.039 DBMET01487 0.124 0.039 DBMET01488 0.124 0.039 DBMET01489 0.124 0.039 DBMET01490 0.107 0.051 DBMET01491 | ||
| 0.118 | 0.016 | 0.118 | Protein kinase C alpha inhibitor | 0.092 0.026 DBMET01486 0.092 0.026 DBMET01487 0.092 0.026 DBMET01488 0.092 0.026 DBMET01489 0.092 0.026 DBMET01490 | ||
| 0.129 | 0.027 | 0.129 | Protein kinase C zeta inhibitor | 0.127 0.028 DBMET01486 0.127 0.028 DBMET01487 0.127 0.028 DBMET01488 0.127 0.028 DBMET01489 0.127 0.028 DBMET01490 0.122 0.031 DBMET01491 | ||
| 0.187 | 0.085 | 0.388 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.207 0.066 DBMET01486 0.207 0.066 DBMET01487 0.207 0.066 DBMET01488 0.207 0.066 DBMET01489 0.207 0.066 DBMET01490 0.388 0.009 DBMET01491 | DBMET01491 | |
| 0.137 | 0.037 | 0.219 | AMP-activated protein kinase stimulant | 0.175 0.016 DBMET01486 0.175 0.016 DBMET01487 0.175 0.016 DBMET01488 0.175 0.016 DBMET01489 0.175 0.016 DBMET01490 0.219 0.009 DBMET01491 | DBMET01491 | |
| 0.139 | 0.039 | 0.222 | Mucolytic | 0.149 0.033 DBMET01486 0.149 0.033 DBMET01487 0.149 0.033 DBMET01488 0.149 0.033 DBMET01489 0.149 0.033 DBMET01490 0.222 0.009 DBMET01491 | DBMET01491 | |
| 0.107 | 0.008 | 0.115 | Glutamate (mGluR7) antagonist | 0.087 0.02 DBMET01486 0.087 0.02 DBMET01487 0.087 0.02 DBMET01488 0.087 0.02 DBMET01489 0.087 0.02 DBMET01490 0.115 0.005 DBMET01491 | DBMET01491 | |
| 0.199 | 0.101 | 0.449 | Platelet antagonist | 0.259 0.068 DBMET01486 0.259 0.068 DBMET01487 0.259 0.068 DBMET01488 0.259 0.068 DBMET01489 0.259 0.068 DBMET01490 0.449 0.019 DBMET01491 | DBMET01491 | |
| 0.102 | 0.005 | 0.102 | DNA gyrase subunit B inhibitor | 0.077 0.005 DBMET01486 0.077 0.005 DBMET01487 0.077 0.005 DBMET01488 0.077 0.005 DBMET01489 0.077 0.005 DBMET01490 0.035 0.032 DBMET01491 | ||
| 0.146 | 0.049 | 0.159 | Antibacterial (Helicobacter pylori) | 0.142 0.053 DBMET01486 0.142 0.053 DBMET01487 0.142 0.053 DBMET01488 0.142 0.053 DBMET01489 0.142 0.053 DBMET01490 0.159 0.039 DBMET01491 | DBMET01491 | |
| 0.175 | 0.079 | 0.6 | Nitric oxide antagonist | 0.269 0.047 DBMET01486 0.269 0.047 DBMET01487 0.269 0.047 DBMET01488 0.269 0.047 DBMET01489 0.269 0.047 DBMET01490 0.6 0.01 DBMET01491 | DBMET01491 | |
| 0.107 | 0.011 | 0.107 | Nicotinic receptor alpha7 subunit antagonist | 0.06 0.028 DBMET01486 0.06 0.028 DBMET01487 0.06 0.028 DBMET01488 0.06 0.028 DBMET01489 0.06 0.028 DBMET01490 | ||
| 0.145 | 0.052 | 0.43 | DNA polymerase I inhibitor | 0.197 0.029 DBMET01486 0.197 0.029 DBMET01487 0.197 0.029 DBMET01488 0.197 0.029 DBMET01489 0.197 0.029 DBMET01490 0.43 0.005 DBMET01491 | DBMET01491 | |
| 0.101 | 0.009 | 0.112 | Exportin-1 inhibitor | 0.075 0.032 DBMET01486 0.075 0.032 DBMET01487 0.075 0.032 DBMET01488 0.075 0.032 DBMET01489 0.075 0.032 DBMET01490 0.112 0.005 DBMET01491 | DBMET01491 | |
| 0.115 | 0.023 | 0.151 | ATPase (Vacuolar H+) inhibitor | 0.121 0.019 DBMET01486 0.121 0.019 DBMET01487 0.121 0.019 DBMET01488 0.121 0.019 DBMET01489 0.121 0.019 DBMET01490 0.151 0.007 DBMET01491 | DBMET01491 | |
| 0.146 | 0.055 | 0.203 | Heat shock protein 70 antagonist | 0.156 0.034 DBMET01486 0.156 0.034 DBMET01487 0.156 0.034 DBMET01488 0.156 0.034 DBMET01489 0.156 0.034 DBMET01490 0.203 0.006 DBMET01491 | DBMET01491 | |
| 0.118 | 0.027 | 0.131 | Ornithine decarboxylase inhibitor | 0.115 0.03 DBMET01486 0.115 0.03 DBMET01487 0.115 0.03 DBMET01488 0.115 0.03 DBMET01489 0.115 0.03 DBMET01490 0.131 0.019 DBMET01491 | DBMET01491 | |
| 0.105 | 0.015 | 0.182 | Purinergic P2X1 antagonist | 0.121 0.011 DBMET01486 0.121 0.011 DBMET01487 0.121 0.011 DBMET01488 0.121 0.011 DBMET01489 0.121 0.011 DBMET01490 0.182 0.004 DBMET01491 | DBMET01491 | |
| 0.202 | 0.112 | 0.716 | Antioxidant | 0.352 0.046 DBMET01486 0.352 0.046 DBMET01487 0.352 0.046 DBMET01488 0.352 0.046 DBMET01489 0.352 0.046 DBMET01490 0.716 0.005 DBMET01491 | DBMET01491 | |
| 0.111 | 0.022 | 0.131 | Granulocyte macrophage colony stimulating factor agonist | 0.097 0.04 DBMET01486 0.097 0.04 DBMET01487 0.097 0.04 DBMET01488 0.097 0.04 DBMET01489 0.097 0.04 DBMET01490 0.131 0.01 DBMET01491 | DBMET01491 | |
| 0.193 | 0.104 | 0.229 | Antiamyloidogenic | 0.229 0.082 DBMET01486 0.229 0.082 DBMET01487 0.229 0.082 DBMET01488 0.229 0.082 DBMET01489 0.229 0.082 DBMET01490 0.229 0.082 DBMET01491 | DBMET01491 | |
| 0.142 | 0.053 | 0.142 | Death-associated protein kinase 1 inhibitor | 0.123 0.104 DBMET01486 0.123 0.104 DBMET01487 0.123 0.104 DBMET01488 0.123 0.104 DBMET01489 0.123 0.104 DBMET01490 | ||
| 0.143 | 0.056 | 0.143 | Cholinergic antagonist | 0.109 0.085 DBMET01486 0.109 0.085 DBMET01487 0.109 0.085 DBMET01488 0.109 0.085 DBMET01489 0.109 0.085 DBMET01490 0.114 0.08 DBMET01491 | ||
| 0.149 | 0.063 | 0.149 | Cytokine production inhibitor | |||
| 0.118 | 0.033 | 0.135 | Potassium channel activator | 0.117 0.034 DBMET01486 0.117 0.034 DBMET01487 0.117 0.034 DBMET01488 0.117 0.034 DBMET01489 0.117 0.034 DBMET01490 0.135 0.026 DBMET01491 | DBMET01491 | |
| 0.112 | 0.028 | 0.356 | Histidine decarboxylase inhibitor | 0.13 0.023 DBMET01486 0.13 0.023 DBMET01487 0.13 0.023 DBMET01488 0.13 0.023 DBMET01489 0.13 0.023 DBMET01490 0.356 0.005 DBMET01491 | DBMET01491 | |
| 0.089 | 0.004 | 0.09 | Pregnane X receptor antagonist | 0.084 0.005 DBMET01486 0.084 0.005 DBMET01487 0.084 0.005 DBMET01488 0.084 0.005 DBMET01489 0.084 0.005 DBMET01490 0.09 0.004 DBMET01491 | DBMET01491 | |
| 0.11 | 0.026 | 0.36 | Glutamate dehydrogenase inhibitor | 0.126 0.021 DBMET01486 0.126 0.021 DBMET01487 0.126 0.021 DBMET01488 0.126 0.021 DBMET01489 0.126 0.021 DBMET01490 0.36 0.004 DBMET01491 | DBMET01491 | |
| 0.149 | 0.064 | 0.468 | Amylase inhibitor | 0.249 0.028 DBMET01486 0.249 0.028 DBMET01487 0.249 0.028 DBMET01488 0.249 0.028 DBMET01489 0.249 0.028 DBMET01490 0.468 0.007 DBMET01491 | DBMET01491 | |
| 0.14 | 0.056 | 0.14 | Acetylcholine antagonist | 0.105 0.085 DBMET01486 0.105 0.085 DBMET01487 0.105 0.085 DBMET01488 0.105 0.085 DBMET01489 0.105 0.085 DBMET01490 0.109 0.081 DBMET01491 | ||
| 0.096 | 0.012 | 0.096 | Fatty acid synthase inhibitor | 0.094 0.013 DBMET01486 0.094 0.013 DBMET01487 0.094 0.013 DBMET01488 0.094 0.013 DBMET01489 0.094 0.013 DBMET01490 0.083 0.017 DBMET01491 | ||
| 0.154 | 0.071 | 0.519 | Insulin secretagoues | 0.221 0.027 DBMET01486 0.221 0.027 DBMET01487 0.221 0.027 DBMET01488 0.221 0.027 DBMET01489 0.221 0.027 DBMET01490 0.519 0.005 DBMET01491 | DBMET01491 | |
| 0.097 | 0.014 | 0.097 | Transcription factor AP-1 inhibitor | 0.088 0.017 DBMET01486 0.088 0.017 DBMET01487 0.088 0.017 DBMET01488 0.088 0.017 DBMET01489 0.088 0.017 DBMET01490 0.063 0.04 DBMET01491 | ||
| 0.15 | 0.068 | 0.213 | Hemostatic | 0.172 0.047 DBMET01486 0.172 0.047 DBMET01487 0.172 0.047 DBMET01488 0.172 0.047 DBMET01489 0.172 0.047 DBMET01490 0.213 0.028 DBMET01491 | DBMET01491 | |
| 0.088 | 0.005 | 0.101 | Ryanodine receptor antagonist | 0.087 0.006 DBMET01486 0.087 0.006 DBMET01487 0.087 0.006 DBMET01488 0.087 0.006 DBMET01489 0.087 0.006 DBMET01490 0.101 0.004 DBMET01491 | DBMET01491 | |
| 0.128 | 0.045 | 0.287 | GABA C receptor antagonist | 0.111 0.063 DBMET01486 0.111 0.063 DBMET01487 0.111 0.063 DBMET01488 0.111 0.063 DBMET01489 0.111 0.063 DBMET01490 0.287 0.005 DBMET01491 | DBMET01491 | |
| 0.191 | 0.11 | 0.73 | Aldehyde oxidase inhibitor | 0.211 0.099 DBMET01486 0.211 0.099 DBMET01487 0.211 0.099 DBMET01488 0.211 0.099 DBMET01489 0.211 0.099 DBMET01490 0.73 0.006 DBMET01491 | DBMET01491 | |
| 0.1 | 0.02 | 0.102 | Phosphodiesterase VI inhibitor | 0.102 0.019 DBMET01486 0.102 0.019 DBMET01487 0.102 0.019 DBMET01488 0.102 0.019 DBMET01489 0.102 0.019 DBMET01490 0.09 0.028 DBMET01491 | DBMET01490 | |
| 0.135 | 0.056 | 0.227 | Alkylator | 0.162 0.041 DBMET01486 0.162 0.041 DBMET01487 0.162 0.041 DBMET01488 0.162 0.041 DBMET01489 0.162 0.041 DBMET01490 0.227 0.02 DBMET01491 | DBMET01491 | |
| 0.163 | 0.085 | 0.175 | Tumour necrosis factor antagonist | 0.175 0.072 DBMET01491 | DBMET01491 | |
| 0.106 | 0.03 | 0.121 | Cell adhesion molecule inhibitor | 0.119 0.024 DBMET01486 0.119 0.024 DBMET01487 0.119 0.024 DBMET01488 0.119 0.024 DBMET01489 0.119 0.024 DBMET01490 0.121 0.024 DBMET01491 | DBMET01491 | |
| 0.085 | 0.01 | 0.085 | Thromboxane synthase inhibitor | 0.071 0.017 DBMET01486 0.071 0.017 DBMET01487 0.071 0.017 DBMET01488 0.071 0.017 DBMET01489 0.071 0.017 DBMET01490 0.052 0.044 DBMET01491 | ||
| 0.084 | 0.008 | 0.098 | Squalene epoxidase inhibitor | 0.082 0.009 DBMET01486 0.082 0.009 DBMET01487 0.082 0.009 DBMET01488 0.082 0.009 DBMET01489 0.082 0.009 DBMET01490 0.098 0.005 DBMET01491 | DBMET01491 | |
| 0.161 | 0.086 | 0.48 | Phospholipase C inhibitor | 0.204 0.041 DBMET01486 0.204 0.041 DBMET01487 0.204 0.041 DBMET01488 0.204 0.041 DBMET01489 0.204 0.041 DBMET01490 0.48 0.007 DBMET01491 | DBMET01491 | |
| 0.082 | 0.007 | 0.082 | Glutamate (mGluR group III) antagonist | 0.06 0.013 DBMET01486 0.06 0.013 DBMET01487 0.06 0.013 DBMET01488 0.06 0.013 DBMET01489 0.06 0.013 DBMET01490 0.055 0.016 DBMET01491 | ||
| 0.082 | 0.008 | 0.082 | Glutamate (mGluR4) antagonist | 0.054 0.018 DBMET01486 0.054 0.018 DBMET01487 0.054 0.018 DBMET01488 0.054 0.018 DBMET01489 0.054 0.018 DBMET01490 0.047 0.025 DBMET01491 | ||
| 0.131 | 0.058 | 0.131 | Proteasome inhibitor | 0.103 0.083 DBMET01486 0.103 0.083 DBMET01487 0.103 0.083 DBMET01488 0.103 0.083 DBMET01489 0.103 0.083 DBMET01490 0.116 0.069 DBMET01491 | ||
| 0.196 | 0.124 | 0.719 | 5 Hydroxytryptamine release stimulant | 0.205 0.117 DBMET01486 0.205 0.117 DBMET01487 0.205 0.117 DBMET01488 0.205 0.117 DBMET01489 0.205 0.117 DBMET01490 0.719 0.006 DBMET01491 | DBMET01491 | |
| 0.151 | 0.081 | 0.339 | Thrombolytic | 0.202 0.051 DBMET01486 0.202 0.051 DBMET01487 0.202 0.051 DBMET01488 0.202 0.051 DBMET01489 0.202 0.051 DBMET01490 0.339 0.018 DBMET01491 | DBMET01491 | |
| 0.15 | 0.079 | 0.317 | Hexokinase inhibitor | 0.192 0.04 DBMET01486 0.192 0.04 DBMET01487 0.192 0.04 DBMET01488 0.192 0.04 DBMET01489 0.192 0.04 DBMET01490 0.317 0.009 DBMET01491 | DBMET01491 | |
| 0.179 | 0.109 | 0.232 | 5 Hydroxytryptamine 3E antagonist | 0.232 0.026 DBMET01491 | DBMET01491 | |
| 0.207 | 0.138 | 0.328 | Gastrin inhibitor | 0.197 0.153 DBMET01486 0.197 0.153 DBMET01487 0.197 0.153 DBMET01488 0.197 0.153 DBMET01489 0.197 0.153 DBMET01490 0.328 0.018 DBMET01491 | DBMET01491 | |
| 0.174 | 0.107 | 0.174 | EphB2 antagonist | |||
| 0.087 | 0.02 | 0.087 | Glutamate (mGluR1) antagonist | |||
| 0.116 | 0.05 | 0.187 | DOPA decarboxylase inhibitor | 0.114 0.052 DBMET01486 0.114 0.052 DBMET01487 0.114 0.052 DBMET01488 0.114 0.052 DBMET01489 0.114 0.052 DBMET01490 0.187 0.009 DBMET01491 | DBMET01491 | |
| 0.089 | 0.023 | 0.128 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.083 0.032 DBMET01486 0.083 0.032 DBMET01487 0.083 0.032 DBMET01488 0.083 0.032 DBMET01489 0.083 0.032 DBMET01490 0.128 0.005 DBMET01491 | DBMET01491 | |
| 0.069 | 0.004 | 0.069 | Vanilloid 3 antagonist | 0.062 0.005 DBMET01486 0.062 0.005 DBMET01487 0.062 0.005 DBMET01488 0.062 0.005 DBMET01489 0.062 0.005 DBMET01490 0.065 0.004 DBMET01491 | ||
| 0.179 | 0.115 | 0.192 | Aryl hydrocarbon receptor agonist | 0.146 0.139 DBMET01486 0.146 0.139 DBMET01487 0.146 0.139 DBMET01488 0.146 0.139 DBMET01489 0.146 0.139 DBMET01490 0.192 0.107 DBMET01491 | DBMET01491 | |
| 0.208 | 0.144 | 0.3 | Insulysin inhibitor | 0.3 0.058 DBMET01491 | DBMET01491 | |
| 0.114 | 0.051 | 0.191 | Beta glucuronidase inhibitor | 0.148 0.026 DBMET01486 0.148 0.026 DBMET01487 0.148 0.026 DBMET01488 0.148 0.026 DBMET01489 0.148 0.026 DBMET01490 0.191 0.014 DBMET01491 | DBMET01491 | |
| 0.118 | 0.056 | 0.202 | Chelator | 0.151 0.035 DBMET01486 0.151 0.035 DBMET01487 0.151 0.035 DBMET01488 0.151 0.035 DBMET01489 0.151 0.035 DBMET01490 0.202 0.024 DBMET01491 | DBMET01491 | |
| 0.069 | 0.007 | 0.076 | Microtubule stabilization | 0.07 0.006 DBMET01486 0.07 0.006 DBMET01487 0.07 0.006 DBMET01488 0.07 0.006 DBMET01489 0.07 0.006 DBMET01490 0.076 0.005 DBMET01491 | DBMET01491 | |
| 0.111 | 0.049 | 0.111 | Hedgehog signaling inhibitor | |||
| 0.104 | 0.042 | 0.141 | Histamine N-methyltransferase inhibitor | 0.082 0.064 DBMET01486 0.082 0.064 DBMET01487 0.082 0.064 DBMET01488 0.082 0.064 DBMET01489 0.082 0.064 DBMET01490 0.141 0.018 DBMET01491 | DBMET01491 | |
| 0.087 | 0.025 | 0.087 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.075 | 0.014 | 0.075 | Oleamide hydrolase inhibitor | |||
| 0.081 | 0.021 | 0.081 | Nitric oxide donor | 0.079 0.023 DBMET01486 0.079 0.023 DBMET01487 0.079 0.023 DBMET01488 0.079 0.023 DBMET01489 0.079 0.023 DBMET01490 0.081 0.022 DBMET01491 | ||
| 0.073 | 0.014 | 0.132 | Glucose-6-phosphate translocase inhibitor | 0.091 0.008 DBMET01486 0.091 0.008 DBMET01487 0.091 0.008 DBMET01488 0.091 0.008 DBMET01489 0.091 0.008 DBMET01490 0.132 0.004 DBMET01491 | DBMET01491 | |
| 0.126 | 0.068 | 0.179 | Cathepsin H inhibitor | 0.179 0.03 DBMET01491 | DBMET01491 | |
| 0.091 | 0.033 | 0.172 | Aminopeptidase I inhibitor | 0.088 0.035 DBMET01486 0.088 0.035 DBMET01487 0.088 0.035 DBMET01488 0.088 0.035 DBMET01489 0.088 0.035 DBMET01490 0.172 0.009 DBMET01491 | DBMET01491 | |
| 0.065 | 0.007 | 0.065 | Nerve growth factor antagonist | 0.054 0.014 DBMET01486 0.054 0.014 DBMET01487 0.054 0.014 DBMET01488 0.054 0.014 DBMET01489 0.054 0.014 DBMET01490 0.054 0.014 DBMET01491 | ||
| 0.187 | 0.129 | 0.39 | Immunostimulant | 0.276 0.086 DBMET01486 0.276 0.086 DBMET01487 0.276 0.086 DBMET01488 0.276 0.086 DBMET01489 0.276 0.086 DBMET01490 0.39 0.053 DBMET01491 | DBMET01491 | |
| 0.08 | 0.022 | 0.249 | Acyl-CoA dehydrogenase inhibitor | 0.089 0.019 DBMET01486 0.089 0.019 DBMET01487 0.089 0.019 DBMET01488 0.089 0.019 DBMET01489 0.089 0.019 DBMET01490 0.249 0.003 DBMET01491 | DBMET01491 | |
| 0.069 | 0.011 | 0.069 | Glutamate (mGluR1a) antagonist | |||
| 0.096 | 0.041 | 0.096 | Acetylcholine nicotinic agonist | |||
| 0.102 | 0.047 | 0.102 | Calcium antagonist | 0.102 0.047 DBMET01491 | ||
| 0.07 | 0.015 | 0.07 | Prolyl endopeptidase inhibitor | 0.06 0.024 DBMET01486 0.06 0.024 DBMET01487 0.06 0.024 DBMET01488 0.06 0.024 DBMET01489 0.06 0.024 DBMET01490 0.059 0.025 DBMET01491 | ||
| 0.081 | 0.027 | 0.081 | Aromatase inhibitor | 0.071 0.033 DBMET01486 0.071 0.033 DBMET01487 0.071 0.033 DBMET01488 0.071 0.033 DBMET01489 0.071 0.033 DBMET01490 0.072 0.033 DBMET01491 | ||
| 0.106 | 0.053 | 0.35 | Creatine kinase inhibitor | 0.125 0.037 DBMET01486 0.125 0.037 DBMET01487 0.125 0.037 DBMET01488 0.125 0.037 DBMET01489 0.125 0.037 DBMET01490 0.35 0.003 DBMET01491 | DBMET01491 | |
| 0.089 | 0.036 | 0.214 | Glutamate decarboxylase inhibitor | 0.087 0.038 DBMET01486 0.087 0.038 DBMET01487 0.087 0.038 DBMET01488 0.087 0.038 DBMET01489 0.087 0.038 DBMET01490 0.214 0.006 DBMET01491 | DBMET01491 | |
| 0.173 | 0.12 | 0.629 | Free radical scavenger | 0.32 0.046 DBMET01486 0.32 0.046 DBMET01487 0.32 0.046 DBMET01488 0.32 0.046 DBMET01489 0.32 0.046 DBMET01490 0.629 0.007 DBMET01491 | DBMET01491 | |
| 0.196 | 0.144 | 0.296 | Transcription factor STAT inhibitor | 0.192 0.151 DBMET01486 0.192 0.151 DBMET01487 0.192 0.151 DBMET01488 0.192 0.151 DBMET01489 0.192 0.151 DBMET01490 0.296 0.058 DBMET01491 | DBMET01491 | |
| 0.081 | 0.028 | 0.417 | Carbamoyl phosphate synthetase inhibitor | 0.096 0.022 DBMET01486 0.096 0.022 DBMET01487 0.096 0.022 DBMET01488 0.096 0.022 DBMET01489 0.096 0.022 DBMET01490 0.417 0.003 DBMET01491 | DBMET01491 | |
| 0.133 | 0.081 | 0.412 | Lipid peroxidase inhibitor | 0.204 0.04 DBMET01486 0.204 0.04 DBMET01487 0.204 0.04 DBMET01488 0.204 0.04 DBMET01489 0.204 0.04 DBMET01490 0.412 0.009 DBMET01491 | DBMET01491 | |
| 0.095 | 0.044 | 0.207 | Transcription factor NF kappa B stimulant | 0.117 0.027 DBMET01486 0.117 0.027 DBMET01487 0.117 0.027 DBMET01488 0.117 0.027 DBMET01489 0.117 0.027 DBMET01490 0.207 0.009 DBMET01491 | DBMET01491 | |
| 0.106 | 0.057 | 0.226 | Bronchodilator | 0.102 0.061 DBMET01486 0.102 0.061 DBMET01487 0.102 0.061 DBMET01488 0.102 0.061 DBMET01489 0.102 0.061 DBMET01490 0.226 0.015 DBMET01491 | DBMET01491 | |
| 0.093 | 0.044 | 0.21 | Carbonic anhydrase VI inhibitor | 0.117 0.031 DBMET01486 0.117 0.031 DBMET01487 0.117 0.031 DBMET01488 0.117 0.031 DBMET01489 0.117 0.031 DBMET01490 0.21 0.012 DBMET01491 | DBMET01491 | |
| 0.139 | 0.091 | 0.153 | Protein-tyrosine phosphatase inhibitor | 0.148 0.08 DBMET01486 0.148 0.08 DBMET01487 0.148 0.08 DBMET01488 0.148 0.08 DBMET01489 0.148 0.08 DBMET01490 0.153 0.075 DBMET01491 | DBMET01491 | |
| 0.184 | 0.136 | 0.301 | Cardiotonic | 0.182 0.137 DBMET01486 0.182 0.137 DBMET01487 0.182 0.137 DBMET01488 0.182 0.137 DBMET01489 0.182 0.137 DBMET01490 0.301 0.055 DBMET01491 | DBMET01491 | |
| 0.108 | 0.06 | 0.259 | Expectorant | 0.144 0.038 DBMET01486 0.144 0.038 DBMET01487 0.144 0.038 DBMET01488 0.144 0.038 DBMET01489 0.144 0.038 DBMET01490 0.259 0.012 DBMET01491 | DBMET01491 | |
| 0.156 | 0.11 | 0.216 | Pyruvate kinase inhibitor | 0.153 0.113 DBMET01486 0.153 0.113 DBMET01487 0.153 0.113 DBMET01488 0.153 0.113 DBMET01489 0.153 0.113 DBMET01490 0.216 0.073 DBMET01491 | DBMET01491 | |
| 0.074 | 0.028 | 0.282 | Argininosuccinate synthase inhibitor | 0.089 0.022 DBMET01486 0.089 0.022 DBMET01487 0.089 0.022 DBMET01488 0.089 0.022 DBMET01489 0.089 0.022 DBMET01490 0.282 0.004 DBMET01491 | DBMET01491 | |
| 0.194 | 0.147 | 0.402 | Tyrosine 3 hydroxylase inhibitor | 0.183 0.169 DBMET01486 0.183 0.169 DBMET01487 0.183 0.169 DBMET01488 0.183 0.169 DBMET01489 0.183 0.169 DBMET01490 0.402 0.008 DBMET01491 | DBMET01491 | |
| 0.105 | 0.059 | 0.13 | Gastric antisecretory | 0.094 0.073 DBMET01486 0.094 0.073 DBMET01487 0.094 0.073 DBMET01488 0.094 0.073 DBMET01489 0.094 0.073 DBMET01490 0.13 0.036 DBMET01491 | DBMET01491 | |
| 0.089 | 0.044 | 0.194 | Carbonic anhydrase XIII inhibitor | 0.115 0.031 DBMET01486 0.115 0.031 DBMET01487 0.115 0.031 DBMET01488 0.115 0.031 DBMET01489 0.115 0.031 DBMET01490 0.194 0.015 DBMET01491 | DBMET01491 | |
| 0.114 | 0.069 | 0.163 | Interleukin 8 antagonist | 0.113 0.072 DBMET01486 0.113 0.072 DBMET01487 0.113 0.072 DBMET01488 0.113 0.072 DBMET01489 0.113 0.072 DBMET01490 0.163 0.027 DBMET01491 | DBMET01491 | |
| 0.089 | 0.044 | 0.205 | Glycine receptor antagonist | 0.112 0.023 DBMET01486 0.112 0.023 DBMET01487 0.112 0.023 DBMET01488 0.112 0.023 DBMET01489 0.112 0.023 DBMET01490 0.205 0.003 DBMET01491 | DBMET01491 | |
| 0.105 | 0.062 | 0.199 | Aminopeptidase B inhibitor | 0.094 0.07 DBMET01486 0.094 0.07 DBMET01487 0.094 0.07 DBMET01488 0.094 0.07 DBMET01489 0.094 0.07 DBMET01490 0.199 0.021 DBMET01491 | DBMET01491 | |
| 0.049 | 0.006 | 0.049 | Protein kinase C beta II inhibitor | 0.043 0.009 DBMET01486 0.043 0.009 DBMET01487 0.043 0.009 DBMET01488 0.043 0.009 DBMET01489 0.043 0.009 DBMET01490 | ||
| 0.069 | 0.026 | 0.076 | Botulinum neurotoxin type A inhibitor | 0.067 0.029 DBMET01486 0.067 0.029 DBMET01487 0.067 0.029 DBMET01488 0.067 0.029 DBMET01489 0.067 0.029 DBMET01490 0.076 0.02 DBMET01491 | DBMET01491 | |
| 0.098 | 0.055 | 0.098 | Toll-Like receptor 3 antagonist | |||
| 0.118 | 0.076 | 0.118 | Nav1.3 sodium channel blocker | |||
| 0.089 | 0.048 | 0.1 | Inducible nitric-oxide synthase inhibitor | 0.1 0.037 DBMET01491 | DBMET01491 | |
| 0.109 | 0.069 | 0.111 | Nav1.5 sodium channel blocker | 0.111 0.067 DBMET01491 | DBMET01491 | |
| 0.059 | 0.019 | 0.223 | Glucose-6-phosphate isomerase inhibitor | 0.078 0.009 DBMET01486 0.078 0.009 DBMET01487 0.078 0.009 DBMET01488 0.078 0.009 DBMET01489 0.078 0.009 DBMET01490 0.223 0.001 DBMET01491 | DBMET01491 | |
| 0.097 | 0.058 | 0.184 | Prolactin inhibitor | 0.083 0.077 DBMET01486 0.083 0.077 DBMET01487 0.083 0.077 DBMET01488 0.083 0.077 DBMET01489 0.083 0.077 DBMET01490 0.184 0.012 DBMET01491 | DBMET01491 | |
| 0.068 | 0.029 | 0.068 | Potassium channel intermediate-conductance Ca-activated blocker | 0.058 0.046 DBMET01491 | ||
| 0.079 | 0.04 | 0.222 | Glycine receptor agonist | 0.086 0.032 DBMET01486 0.086 0.032 DBMET01487 0.086 0.032 DBMET01488 0.086 0.032 DBMET01489 0.086 0.032 DBMET01490 0.222 0.004 DBMET01491 | DBMET01491 | |
| 0.047 | 0.009 | 0.077 | Uridine phosphorylase inhibitor | 0.052 0.007 DBMET01486 0.052 0.007 DBMET01487 0.052 0.007 DBMET01488 0.052 0.007 DBMET01489 0.052 0.007 DBMET01490 0.077 0.004 DBMET01491 | DBMET01491 | |
| 0.055 | 0.017 | 0.079 | Guanylate cyclase inhibitor | 0.058 0.014 DBMET01486 0.058 0.014 DBMET01487 0.058 0.014 DBMET01488 0.058 0.014 DBMET01489 0.058 0.014 DBMET01490 0.079 0.003 DBMET01491 | DBMET01491 | |
| 0.072 | 0.036 | 0.153 | Glutamate (mGluR6) antagonist | 0.073 0.033 DBMET01486 0.073 0.033 DBMET01487 0.073 0.033 DBMET01488 0.073 0.033 DBMET01489 0.073 0.033 DBMET01490 0.153 0.004 DBMET01491 | DBMET01491 | |
| 0.132 | 0.095 | 0.206 | Heat shock protein 90 antagonist | 0.158 0.066 DBMET01486 0.158 0.066 DBMET01487 0.158 0.066 DBMET01488 0.158 0.066 DBMET01489 0.158 0.066 DBMET01490 0.206 0.035 DBMET01491 | DBMET01491 | |
| 0.043 | 0.007 | 0.043 | Protein kinase C beta I inhibitor | 0.04 0.009 DBMET01486 0.04 0.009 DBMET01487 0.04 0.009 DBMET01488 0.04 0.009 DBMET01489 0.04 0.009 DBMET01490 0.035 0.02 DBMET01491 | ||
| 0.05 | 0.014 | 0.064 | Farnesoid X receptor agonist | 0.052 0.013 DBMET01486 0.052 0.013 DBMET01487 0.052 0.013 DBMET01488 0.052 0.013 DBMET01489 0.052 0.013 DBMET01490 0.064 0.009 DBMET01491 | DBMET01491 | |
| 0.044 | 0.009 | 0.044 | Methionyl aminopeptidase 1 inhibitor | 0.032 0.023 DBMET01491 | ||
| 0.107 | 0.072 | 0.146 | Protein-tyrosine phosphatase 1B inhibitor | 0.122 0.062 DBMET01486 0.122 0.062 DBMET01487 0.122 0.062 DBMET01488 0.122 0.062 DBMET01489 0.122 0.062 DBMET01490 0.146 0.047 DBMET01491 | DBMET01491 | |
| 0.056 | 0.021 | 0.056 | Glutamate (mGluR5) agonist | |||
| 0.058 | 0.024 | 0.072 | Lysophosphatidic acid 3 receptor antagonist | 0.047 0.041 DBMET01486 0.047 0.041 DBMET01487 0.047 0.041 DBMET01488 0.047 0.041 DBMET01489 0.047 0.041 DBMET01490 0.072 0.013 DBMET01491 | DBMET01491 | |
| 0.057 | 0.023 | 0.089 | Adenosine deaminase inhibitor | 0.064 0.017 DBMET01486 0.064 0.017 DBMET01487 0.064 0.017 DBMET01488 0.064 0.017 DBMET01489 0.064 0.017 DBMET01490 0.089 0.007 DBMET01491 | DBMET01491 | |
| 0.057 | 0.024 | 0.057 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.244 | 0.212 | 0.317 | Calcium channel L-type activator | 0.248 0.207 DBMET01486 0.248 0.207 DBMET01487 0.248 0.207 DBMET01488 0.248 0.207 DBMET01489 0.248 0.207 DBMET01490 0.317 0.143 DBMET01491 | DBMET01491 | |
| 0.108 | 0.076 | 0.264 | Cell adhesion inhibitor | 0.154 0.044 DBMET01486 0.154 0.044 DBMET01487 0.154 0.044 DBMET01488 0.154 0.044 DBMET01489 0.154 0.044 DBMET01490 0.264 0.013 DBMET01491 | DBMET01491 | |
| 0.055 | 0.023 | 0.07 | Cholesterol esterase inhibitor | 0.051 0.028 DBMET01486 0.051 0.028 DBMET01487 0.051 0.028 DBMET01488 0.051 0.028 DBMET01489 0.051 0.028 DBMET01490 0.07 0.01 DBMET01491 | DBMET01491 | |
| 0.122 | 0.091 | 0.122 | Protein kinase C nu inhibitor | |||
| 0.056 | 0.025 | 0.056 | Glutamate (mGluR group I) agonist | |||
| 0.058 | 0.027 | 0.081 | Heparanase inhibitor | 0.065 0.017 DBMET01486 0.065 0.017 DBMET01487 0.065 0.017 DBMET01488 0.065 0.017 DBMET01489 0.065 0.017 DBMET01490 0.081 0.006 DBMET01491 | DBMET01491 | |
| 0.103 | 0.073 | 0.222 | Monophenol monooxygenase inhibitor | 0.162 0.043 DBMET01486 0.162 0.043 DBMET01487 0.162 0.043 DBMET01488 0.162 0.043 DBMET01489 0.162 0.043 DBMET01490 0.222 0.028 DBMET01491 | DBMET01491 | |
| 0.065 | 0.035 | 0.106 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.082 0.024 DBMET01486 0.082 0.024 DBMET01487 0.082 0.024 DBMET01488 0.082 0.024 DBMET01489 0.082 0.024 DBMET01490 0.106 0.015 DBMET01491 | DBMET01491 | |
| 0.051 | 0.022 | 0.071 | Geranyltranstransferase inhibitor | 0.043 0.031 DBMET01486 0.043 0.031 DBMET01487 0.043 0.031 DBMET01488 0.043 0.031 DBMET01489 0.043 0.031 DBMET01490 0.071 0.007 DBMET01491 | DBMET01491 | |
| 0.185 | 0.157 | 0.287 | Transcription factor STAT3 inhibitor | 0.182 0.16 DBMET01486 0.182 0.16 DBMET01487 0.182 0.16 DBMET01488 0.182 0.16 DBMET01489 0.182 0.16 DBMET01490 0.287 0.06 DBMET01491 | DBMET01491 | |
| 0.059 | 0.031 | 0.162 | Protein 50S ribosomal subunit inhibitor | 0.076 0.021 DBMET01486 0.076 0.021 DBMET01487 0.076 0.021 DBMET01488 0.076 0.021 DBMET01489 0.076 0.021 DBMET01490 0.162 0.006 DBMET01491 | DBMET01491 | |
| 0.051 | 0.024 | 0.051 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.079 | 0.052 | 0.128 | Macrophage migration inhibitory factor inhibitor | 0.083 0.048 DBMET01486 0.083 0.048 DBMET01487 0.083 0.048 DBMET01488 0.083 0.048 DBMET01489 0.083 0.048 DBMET01490 0.128 0.023 DBMET01491 | DBMET01491 | |
| 0.045 | 0.019 | 0.045 | TRPM8 blocker | |||
| 0.134 | 0.109 | 0.279 | CF transmembrane conductance regulator agonist | 0.151 0.074 DBMET01486 0.151 0.074 DBMET01487 0.151 0.074 DBMET01488 0.151 0.074 DBMET01489 0.151 0.074 DBMET01490 0.279 0.004 DBMET01491 | DBMET01491 | |
| 0.133 | 0.108 | 0.181 | Heat shock protein 90 alpha antagonist | 0.138 0.1 DBMET01486 0.138 0.1 DBMET01487 0.138 0.1 DBMET01488 0.138 0.1 DBMET01489 0.138 0.1 DBMET01490 0.181 0.062 DBMET01491 | DBMET01491 | |
| 0.116 | 0.091 | 0.628 | Interleukin 4 antagonist | 0.199 0.022 DBMET01486 0.199 0.022 DBMET01487 0.199 0.022 DBMET01488 0.199 0.022 DBMET01489 0.199 0.022 DBMET01490 0.628 0.004 DBMET01491 | DBMET01491 | |
| 0.054 | 0.029 | 0.093 | Potassium channel (Inward rectifier) activator | 0.05 0.037 DBMET01486 0.05 0.037 DBMET01487 0.05 0.037 DBMET01488 0.05 0.037 DBMET01489 0.05 0.037 DBMET01490 0.093 0.005 DBMET01491 | DBMET01491 | |
| 0.033 | 0.009 | 0.033 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.033 0.009 DBMET01486 0.033 0.009 DBMET01487 0.033 0.009 DBMET01488 0.033 0.009 DBMET01489 0.033 0.009 DBMET01490 0.022 0.012 DBMET01491 | ||
| 0.046 | 0.022 | 0.081 | Thymidine kinase inhibitor | 0.052 0.018 DBMET01486 0.052 0.018 DBMET01487 0.052 0.018 DBMET01488 0.052 0.018 DBMET01489 0.052 0.018 DBMET01490 0.081 0.008 DBMET01491 | DBMET01491 | |
| 0.037 | 0.013 | 0.037 | Nicotinic alpha3beta4 receptor agonist | 0.037 0.012 DBMET01491 | ||
| 0.062 | 0.039 | 0.076 | Cyclin-dependent kinase 6 inhibitor | 0.076 0.025 DBMET01491 | DBMET01491 | |
| 0.032 | 0.009 | 0.045 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.034 0.007 DBMET01486 0.034 0.007 DBMET01487 0.034 0.007 DBMET01488 0.034 0.007 DBMET01489 0.034 0.007 DBMET01490 0.045 0.004 DBMET01491 | DBMET01491 | |
| 0.051 | 0.028 | 0.069 | Aldosterone antagonist | 0.069 0.015 DBMET01491 | DBMET01491 | |
| 0.051 | 0.028 | 0.09 | Potassium channel (ATP-sensitive) activator | 0.047 0.035 DBMET01486 0.047 0.035 DBMET01487 0.047 0.035 DBMET01488 0.047 0.035 DBMET01489 0.047 0.035 DBMET01490 0.09 0.005 DBMET01491 | DBMET01491 | |
| 0.077 | 0.054 | 0.134 | Na+ K+ transporting ATPase inhibitor | 0.099 0.033 DBMET01486 0.099 0.033 DBMET01487 0.099 0.033 DBMET01488 0.099 0.033 DBMET01489 0.099 0.033 DBMET01490 0.134 0.01 DBMET01491 | DBMET01491 | |
| 0.033 | 0.01 | 0.033 | Prostaglandin H2 antagonist | 0.028 0.015 DBMET01486 0.028 0.015 DBMET01487 0.028 0.015 DBMET01488 0.028 0.015 DBMET01489 0.028 0.015 DBMET01490 0.026 0.018 DBMET01491 | ||
| 0.113 | 0.091 | 0.115 | Nav1.2 sodium channel blocker | 0.115 0.089 DBMET01491 | DBMET01491 | |
| 0.041 | 0.02 | 0.041 | Nicotinic acid receptor agonist | 0.033 0.028 DBMET01486 0.033 0.028 DBMET01487 0.033 0.028 DBMET01488 0.033 0.028 DBMET01489 0.033 0.028 DBMET01490 0.037 0.024 DBMET01491 | ||
| 0.088 | 0.067 | 0.179 | Uric acid excretion stimulant | 0.12 0.038 DBMET01486 0.12 0.038 DBMET01487 0.12 0.038 DBMET01488 0.12 0.038 DBMET01489 0.12 0.038 DBMET01490 0.179 0.016 DBMET01491 | DBMET01491 | |
| 0.04 | 0.019 | 0.268 | Fumarate hydratase inhibitor | 0.047 0.015 DBMET01486 0.047 0.015 DBMET01487 0.047 0.015 DBMET01488 0.047 0.015 DBMET01489 0.047 0.015 DBMET01490 0.268 0.003 DBMET01491 | DBMET01491 | |
| 0.041 | 0.02 | 0.093 | Glutamate (mGluR3) antagonist | 0.042 0.019 DBMET01486 0.042 0.019 DBMET01487 0.042 0.019 DBMET01488 0.042 0.019 DBMET01489 0.042 0.019 DBMET01490 0.093 0.005 DBMET01491 | DBMET01491 | |
| 0.088 | 0.067 | 0.209 | HIV-1 integrase (Overall Integration) inhibitor | 0.081 0.076 DBMET01486 0.081 0.076 DBMET01487 0.081 0.076 DBMET01488 0.081 0.076 DBMET01489 0.081 0.076 DBMET01490 0.209 0.01 DBMET01491 | DBMET01491 | |
| 0.07 | 0.05 | 0.083 | Secretase beta inhibitor | 0.083 0.032 DBMET01491 | DBMET01491 | |
| 0.05 | 0.03 | 0.065 | Dopamine beta hydroxylase inhibitor | 0.065 0.011 DBMET01491 | DBMET01491 | |
| 0.051 | 0.031 | 0.105 | Topoisomerase II beta inhibitor | 0.057 0.025 DBMET01486 0.057 0.025 DBMET01487 0.057 0.025 DBMET01488 0.057 0.025 DBMET01489 0.057 0.025 DBMET01490 0.105 0.009 DBMET01491 | DBMET01491 | |
| 0.072 | 0.052 | 0.078 | Lipase inhibitor | 0.075 0.048 DBMET01486 0.075 0.048 DBMET01487 0.075 0.048 DBMET01488 0.075 0.048 DBMET01489 0.075 0.048 DBMET01490 0.078 0.045 DBMET01491 | DBMET01491 | |
| 0.113 | 0.095 | 0.142 | Alkaline phosphatase inhibitor | 0.119 0.087 DBMET01486 0.119 0.087 DBMET01487 0.119 0.087 DBMET01488 0.119 0.087 DBMET01489 0.119 0.087 DBMET01490 0.142 0.065 DBMET01491 | DBMET01491 | |
| 0.041 | 0.022 | 0.042 | Diamine oxidase inhibitor | 0.042 0.021 DBMET01491 | DBMET01491 | |
| 0.03 | 0.013 | 0.034 | Nicotinic acid receptor 2 antagonist | 0.034 0.009 DBMET01491 | DBMET01491 | |
| 0.074 | 0.056 | 0.074 | Glutamate (mGluR) antagonist | |||
| 0.066 | 0.048 | 0.101 | Acetylcholine M5 receptor agonist | 0.101 0.02 DBMET01491 | DBMET01491 | |
| 0.063 | 0.047 | 0.189 | Neuraminidase (influenza) inhibitor | 0.075 0.03 DBMET01486 0.075 0.03 DBMET01487 0.075 0.03 DBMET01488 0.075 0.03 DBMET01489 0.075 0.03 DBMET01490 0.189 0.005 DBMET01491 | DBMET01491 | |
| 0.042 | 0.027 | 0.078 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.043 0.026 DBMET01486 0.043 0.026 DBMET01487 0.043 0.026 DBMET01488 0.043 0.026 DBMET01489 0.043 0.026 DBMET01490 0.078 0.004 DBMET01491 | DBMET01491 | |
| 0.062 | 0.047 | 0.083 | Transcription factor RelA inhibitor | 0.083 0.015 DBMET01491 | DBMET01491 | |
| 0.048 | 0.033 | 0.106 | Antimetabolite | 0.063 0.024 DBMET01486 0.063 0.024 DBMET01487 0.063 0.024 DBMET01488 0.063 0.024 DBMET01489 0.063 0.024 DBMET01490 0.106 0.015 DBMET01491 | DBMET01491 | |
| 0.029 | 0.014 | 0.032 | Glucosylceramidase stimulant | 0.032 0.009 DBMET01491 | DBMET01491 | |
| 0.142 | 0.128 | 0.177 | I kappa B kinase epsilon inhibitor | 0.177 0.092 DBMET01491 | DBMET01491 | |
| 0.057 | 0.043 | 0.057 | Protein kinase C iota inhibitor | |||
| 0.039 | 0.025 | 0.085 | Glutamate (mGluR8) agonist | 0.038 0.027 DBMET01486 0.038 0.027 DBMET01487 0.038 0.027 DBMET01488 0.038 0.027 DBMET01489 0.038 0.027 DBMET01490 0.085 0.004 DBMET01491 | DBMET01491 | |
| 0.047 | 0.034 | 0.047 | Benzodiazepine antagonist | |||
| 0.066 | 0.053 | 0.066 | Glutamate (mGluR group I) antagonist | |||
| 0.026 | 0.013 | 0.026 | Retinoid X gamma receptor agonist | 0.021 0.019 DBMET01486 0.021 0.019 DBMET01487 0.021 0.019 DBMET01488 0.021 0.019 DBMET01489 0.021 0.019 DBMET01490 | ||
| 0.097 | 0.085 | 0.145 | Anesthetic local | 0.145 0.051 DBMET01491 | DBMET01491 | |
| 0.11 | 0.097 | 0.185 | NADPH oxidase inhibitor | 0.115 0.089 DBMET01486 0.115 0.089 DBMET01487 0.115 0.089 DBMET01488 0.115 0.089 DBMET01489 0.115 0.089 DBMET01490 0.185 0.039 DBMET01491 | DBMET01491 | |
| 0.035 | 0.022 | 0.039 | Free fatty acid receptor 1 antagonist | 0.039 0.017 DBMET01491 | DBMET01491 | |
| 0.125 | 0.113 | 0.179 | Pregnane X receptor agonist | 0.179 0.019 DBMET01491 | DBMET01491 | |
| 0.045 | 0.033 | 0.127 | Phosphorylase inhibitor | 0.088 0.015 DBMET01486 0.088 0.015 DBMET01487 0.088 0.015 DBMET01488 0.088 0.015 DBMET01489 0.088 0.015 DBMET01490 0.127 0.009 DBMET01491 | DBMET01491 | |
| 0.029 | 0.018 | 0.067 | Purinergic P2Y15 antagonist | 0.033 0.012 DBMET01486 0.033 0.012 DBMET01487 0.033 0.012 DBMET01488 0.033 0.012 DBMET01489 0.033 0.012 DBMET01490 0.067 0.002 DBMET01491 | DBMET01491 | |
| 0.054 | 0.043 | 0.054 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.076 | 0.066 | 0.076 | Phosphodiesterase IV inhibitor | |||
| 0.088 | 0.078 | 0.126 | Bile acid receptor antagonist | 0.093 0.066 DBMET01486 0.093 0.066 DBMET01487 0.093 0.066 DBMET01488 0.093 0.066 DBMET01489 0.093 0.066 DBMET01490 0.126 0.015 DBMET01491 | DBMET01491 | |
| 0.034 | 0.024 | 0.077 | Tubulin agonist | 0.041 0.014 DBMET01486 0.041 0.014 DBMET01487 0.041 0.014 DBMET01488 0.041 0.014 DBMET01489 0.041 0.014 DBMET01490 0.077 0.004 DBMET01491 | DBMET01491 | |
| 0.091 | 0.081 | 0.202 | Carbonic anhydrase XV inhibitor | 0.202 0.018 DBMET01491 | DBMET01491 | |
| 0.035 | 0.025 | 0.04 | Retinoid X receptor agonist | 0.04 0.023 DBMET01491 | DBMET01491 | |
| 0.123 | 0.114 | 0.162 | Cyclin-dependent kinase 8 inhibitor | 0.162 0.068 DBMET01491 | DBMET01491 | |
| 0.091 | 0.082 | 0.144 | Glutamate (mGluR7) agonist | 0.144 0.014 DBMET01491 | DBMET01491 | |
| 0.085 | 0.076 | 0.215 | Glutamate release inhibitor | 0.086 0.072 DBMET01486 0.086 0.072 DBMET01487 0.086 0.072 DBMET01488 0.086 0.072 DBMET01489 0.086 0.072 DBMET01490 0.215 0.004 DBMET01491 | DBMET01491 | |
| 0.068 | 0.059 | 0.068 | Acetylcholine M4 receptor antagonist | |||
| 0.034 | 0.025 | 0.041 | Retinoid X alpha receptor agonist | 0.041 0.019 DBMET01491 | DBMET01491 | |
| 0.035 | 0.027 | 0.035 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.163 | 0.155 | 0.451 | Interleukin agonist | 0.221 0.102 DBMET01486 0.221 0.102 DBMET01487 0.221 0.102 DBMET01488 0.221 0.102 DBMET01489 0.221 0.102 DBMET01490 0.451 0.013 DBMET01491 | DBMET01491 | |
| 0.028 | 0.02 | 0.028 | Nicotinic alpha4beta2 receptor agonist | 0.027 0.022 DBMET01491 | ||
| 0.171 | 0.164 | 0.241 | 5 Hydroxytryptamine 1E antagonist | 0.241 0.085 DBMET01491 | DBMET01491 | |
| 0.049 | 0.042 | 0.053 | Thromboxane antagonist | 0.053 0.039 DBMET01491 | DBMET01491 | |
| 0.049 | 0.042 | 0.079 | Ribonucleoside-diphosphate reductase inhibitor | 0.055 0.037 DBMET01486 0.055 0.037 DBMET01487 0.055 0.037 DBMET01488 0.055 0.037 DBMET01489 0.055 0.037 DBMET01490 0.079 0.025 DBMET01491 | DBMET01491 | |
| 0.062 | 0.056 | 0.075 | Potassium channel (ATP-sensitive) blocker | 0.075 0.034 DBMET01491 | DBMET01491 | |
| 0.042 | 0.035 | 0.052 | Heme oxygenase inhibitor | 0.052 0.011 DBMET01491 | DBMET01491 | |
| 0.191 | 0.184 | 0.535 | Caspase 3 stimulant | 0.266 0.099 DBMET01486 0.266 0.099 DBMET01487 0.266 0.099 DBMET01488 0.266 0.099 DBMET01489 0.266 0.099 DBMET01490 0.535 0.016 DBMET01491 | DBMET01491 | |
| 0.118 | 0.112 | 0.176 | Acetylcholine M1 receptor antagonist | 0.176 0.054 DBMET01491 | DBMET01491 | |
| 0.032 | 0.026 | 0.041 | Protein kinase (CK2) beta inhibitor | 0.041 0.012 DBMET01491 | DBMET01491 | |
| 0.07 | 0.064 | 0.087 | Potassium channel (Tandem pore domain) blocker | 0.087 0.02 DBMET01491 | DBMET01491 | |
| 0.053 | 0.048 | 0.207 | Prostaglandin EP2 antagonist | 0.074 0.03 DBMET01486 0.074 0.03 DBMET01487 0.074 0.03 DBMET01488 0.074 0.03 DBMET01489 0.074 0.03 DBMET01490 0.207 0.006 DBMET01491 | DBMET01491 | |
| 0.023 | 0.017 | 0.023 | Retinoic acid receptor agonist | |||
| 0.024 | 0.019 | 0.038 | Methionyl aminopeptidase 2 inhibitor | 0.038 0.01 DBMET01491 | DBMET01491 | |
| 0.039 | 0.034 | 0.092 | Kainate receptor agonist | 0.041 0.028 DBMET01486 0.041 0.028 DBMET01487 0.041 0.028 DBMET01488 0.041 0.028 DBMET01489 0.041 0.028 DBMET01490 0.092 0.003 DBMET01491 | DBMET01491 | |
| 0.06 | 0.055 | 0.06 | Kallikrein 7 inhibitor | |||
| 0.047 | 0.042 | 0.195 | Ornithine carbamoyltransferase inhibitor | 0.053 0.037 DBMET01486 0.053 0.037 DBMET01487 0.053 0.037 DBMET01488 0.053 0.037 DBMET01489 0.053 0.037 DBMET01490 0.195 0.007 DBMET01491 | DBMET01491 | |
| 0.066 | 0.062 | 0.126 | Phospholipase D inhibitor | 0.126 0.005 DBMET01491 | DBMET01491 | |
| 0.029 | 0.024 | 0.029 | DNA topoisomerase IV inhibitor | |||
| 0.048 | 0.044 | 0.082 | Ribonucleotide reductase inhibitor | 0.055 0.039 DBMET01486 0.055 0.039 DBMET01487 0.055 0.039 DBMET01488 0.055 0.039 DBMET01489 0.055 0.039 DBMET01490 0.082 0.026 DBMET01491 | DBMET01491 | |
| 0.063 | 0.06 | 0.063 | Amidase inhibitor | |||
| 0.109 | 0.105 | 0.109 | Toll-Like receptor antagonist | 0.108 0.105 DBMET01491 | ||
| 0.017 | 0.013 | 0.017 | CC chemokine 9 receptor antagonist | |||
| 0.033 | 0.029 | 0.033 | Nicotinic acid receptor 2 agonist | |||
| 0.046 | 0.043 | 0.083 | Cytokine production stimulant | 0.047 0.039 DBMET01486 0.047 0.039 DBMET01487 0.047 0.039 DBMET01488 0.047 0.039 DBMET01489 0.047 0.039 DBMET01490 0.083 0.005 DBMET01491 | DBMET01491 | |
| 0.016 | 0.014 | 0.023 | Nicotinic acid receptor 1 antagonist | 0.023 0.006 DBMET01491 | DBMET01491 | |
| 0.097 | 0.094 | 0.124 | Acetylcholine muscarinic antagonist | 0.124 0.063 DBMET01491 | DBMET01491 | |
| 0.058 | 0.056 | 0.058 | Histone deacetylase SIRT3 inhibitor | |||
| 0.111 | 0.109 | 0.149 | Nav1.6 sodium channel blocker | 0.149 0.056 DBMET01491 | DBMET01491 | |
| 0.033 | 0.032 | 0.045 | Tryptophan 5 hydroxylase inhibitor | 0.045 0.009 DBMET01491 | DBMET01491 | |
| 0.085 | 0.084 | 0.134 | Interleukin 12 antagonist | 0.101 0.052 DBMET01486 0.101 0.052 DBMET01487 0.101 0.052 DBMET01488 0.101 0.052 DBMET01489 0.101 0.052 DBMET01490 0.134 0.019 DBMET01491 | DBMET01491 | |
| 0.026 | 0.026 | 0.053 | Hedgehog signaling activator | 0.027 0.021 DBMET01486 0.027 0.021 DBMET01487 0.027 0.021 DBMET01488 0.027 0.021 DBMET01489 0.027 0.021 DBMET01490 0.053 0.003 DBMET01491 | DBMET01491 | |
| 0.034 | 0.034 | 0.071 | Alpha 1d adrenoreceptor agonist | 0.071 0.007 DBMET01491 | DBMET01491 | |
| 0.071 | 0.071 | 0.103 | Adrenaline agonist | 0.103 0.035 DBMET01491 | DBMET01491 | |
| 0.043 | 0.043 | 0.049 | Beta adrenoreceptor agonist | 0.049 0.021 DBMET01491 | DBMET01491 | |
| 0.044 | 0.045 | 0.056 | HCV NS3/NS4A protease inhibitor | 0.056 0.024 DBMET01491 | DBMET01491 | |
| 0.042 | 0.043 | 0.052 | Thromboxane A2 antagonist | 0.052 0.035 DBMET01491 | DBMET01491 | |
| 0.017 | 0.019 | 0.029 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.015 DBMET01486 0.017 0.015 DBMET01487 0.017 0.015 DBMET01488 0.017 0.015 DBMET01489 0.017 0.015 DBMET01490 0.029 0.003 DBMET01491 | DBMET01491 | |
| 0.008 | 0.012 | 0.015 | Purinergic P2Y2 agonist | 0.01 0.008 DBMET01486 0.01 0.008 DBMET01487 0.01 0.008 DBMET01488 0.01 0.008 DBMET01489 0.01 0.008 DBMET01490 0.015 0.003 DBMET01491 | DBMET01491 | |
| 0.083 | 0.087 | 0.253 | Carbonic anhydrase III inhibitor | 0.105 0.057 DBMET01486 0.105 0.057 DBMET01487 0.105 0.057 DBMET01488 0.105 0.057 DBMET01489 0.105 0.057 DBMET01490 0.253 0.009 DBMET01491 | DBMET01491 | |
| 0.073 | 0.078 | 0.083 | Caspase 7 inhibitor | 0.083 0.055 DBMET01491 | DBMET01491 | |
| 0.018 | 0.023 | 0.022 | Retinoid X beta receptor antagonist | 0.022 0.01 DBMET01491 | DBMET01491 | |
| 0.036 | 0.042 | 0.051 | Glutamate (mGluR group III) agonist | 0.051 0.023 DBMET01491 | DBMET01491 | |
| 0.109 | 0.115 | 0.229 | Neurotrophic factor | 0.131 0.079 DBMET01486 0.131 0.079 DBMET01487 0.131 0.079 DBMET01488 0.131 0.079 DBMET01489 0.131 0.079 DBMET01490 0.229 0.017 DBMET01491 | DBMET01491 | |
| 0.033 | 0.04 | 0.037 | Potassium channel Kv1.1 blocker | 0.037 0.028 DBMET01491 | DBMET01491 | |
| 0.127 | 0.134 | 0.288 | DNA methyltransferase I inhibitor | 0.146 0.108 DBMET01486 0.146 0.108 DBMET01487 0.146 0.108 DBMET01488 0.146 0.108 DBMET01489 0.146 0.108 DBMET01490 0.288 0.031 DBMET01491 | DBMET01491 | |
| 0.021 | 0.028 | 0.128 | RNA-directed RNA polymerase stimulant | 0.031 0.02 DBMET01486 0.031 0.02 DBMET01487 0.031 0.02 DBMET01488 0.031 0.02 DBMET01489 0.031 0.02 DBMET01490 0.128 0.005 DBMET01491 | DBMET01491 | |
| 0.013 | 0.021 | 0.03 | Cyclin T1 inhibitor | 0.03 0.005 DBMET01491 | DBMET01491 | |
| 0.028 | 0.036 | 0.123 | Phosphoglycerate kinase inhibitor | 0.039 0.021 DBMET01486 0.039 0.021 DBMET01487 0.039 0.021 DBMET01488 0.039 0.021 DBMET01489 0.039 0.021 DBMET01490 0.123 0.005 DBMET01491 | DBMET01491 | |
| 0.044 | 0.052 | 0.048 | 5 Hydroxytryptamine 4 antagonist | 0.048 0.043 DBMET01491 | DBMET01491 | |
| 0.077 | 0.085 | 0.182 | Alcohol dehydrogenase inhibitor | 0.086 0.069 DBMET01486 0.086 0.069 DBMET01487 0.086 0.069 DBMET01488 0.086 0.069 DBMET01489 0.086 0.069 DBMET01490 0.182 0.014 DBMET01491 | DBMET01491 | |
| 0.019 | 0.028 | 0.03 | Kynurenine 3 monooxygenase inhibitor | 0.03 0.015 DBMET01491 | DBMET01491 | |
| 0.062 | 0.071 | 0.147 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.068 0.063 DBMET01486 0.068 0.063 DBMET01487 0.068 0.063 DBMET01488 0.068 0.063 DBMET01489 0.068 0.063 DBMET01490 0.147 0.02 DBMET01491 | DBMET01491 | |
| 0.01 | 0.02 | 0.017 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.017 0.005 DBMET01491 | DBMET01491 | |
| 0.129 | 0.14 | 0.294 | DNA methylase inhibitor | 0.162 0.107 DBMET01486 0.162 0.107 DBMET01487 0.162 0.107 DBMET01488 0.162 0.107 DBMET01489 0.162 0.107 DBMET01490 0.294 0.03 DBMET01491 | DBMET01491 | |
| 0.061 | 0.072 | 0.088 | MDM2 inhibitor | 0.088 0.012 DBMET01491 | DBMET01491 | |
| 0.03 | 0.042 | 0.035 | Urate transporter 1 inhibitor | 0.035 0.032 DBMET01491 | DBMET01491 | |
| 0.104 | 0.115 | 0.181 | DNA repair enzyme inhibitor | 0.114 0.086 DBMET01486 0.114 0.086 DBMET01487 0.114 0.086 DBMET01488 0.114 0.086 DBMET01489 0.114 0.086 DBMET01490 0.181 0.013 DBMET01491 | DBMET01491 | |
| 0.03 | 0.042 | 0.094 | Toll-Like receptor 2 agonist | 0.094 0.015 DBMET01491 | DBMET01491 | |
| 0.039 | 0.051 | 0.093 | Carbonic anhydrase XIV inhibitor | 0.048 0.035 DBMET01486 0.048 0.035 DBMET01487 0.048 0.035 DBMET01488 0.048 0.035 DBMET01489 0.048 0.035 DBMET01490 0.093 0.013 DBMET01491 | DBMET01491 | |
| 0.019 | 0.031 | 0.042 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.042 0.01 DBMET01491 | DBMET01491 | |
| 0.037 | 0.05 | 0.045 | Histamine H1 receptor agonist | 0.045 0.027 DBMET01491 | DBMET01491 | |
| 0.045 | 0.057 | 0.187 | HIV-1 integrase (Strand Transfer) inhibitor | 0.075 0.033 DBMET01486 0.075 0.033 DBMET01487 0.075 0.033 DBMET01488 0.075 0.033 DBMET01489 0.075 0.033 DBMET01490 0.187 0.01 DBMET01491 | DBMET01491 | |
| 0.015 | 0.028 | 0.018 | Alpha 2b adrenoreceptor agonist | 0.018 0.015 DBMET01491 | DBMET01491 | |
| 0.001 | 0.013 | 0.003 | Purinergic P2Y6 agonist | 0.003 0.002 DBMET01491 | DBMET01491 | |
| 0.044 | 0.057 | 0.284 | Alpha-mannosidase inhibitor | 0.064 0.022 DBMET01486 0.064 0.022 DBMET01487 0.064 0.022 DBMET01488 0.064 0.022 DBMET01489 0.064 0.022 DBMET01490 0.284 0.002 DBMET01491 | DBMET01491 | |
| 0.081 | 0.094 | 0.165 | Falcipain 3 inhibitor | 0.165 0.03 DBMET01491 | DBMET01491 | |
| 0.02 | 0.034 | 0.057 | Vanilloid 2 agonist | 0.024 0.021 DBMET01486 0.024 0.021 DBMET01487 0.024 0.021 DBMET01488 0.024 0.021 DBMET01489 0.024 0.021 DBMET01490 0.057 0.002 DBMET01491 | DBMET01491 | |
| 0.019 | 0.033 | 0.023 | ICAM 1 antagonist | 0.023 0.016 DBMET01491 | DBMET01491 | |
| 0.016 | 0.03 | 0.021 | Lysophosphatidic acid 1 receptor antagonist | 0.021 0.015 DBMET01491 | DBMET01491 | |
| 0.013 | 0.027 | 0.046 | Telomerase stimulant | 0.016 0.014 DBMET01486 0.016 0.014 DBMET01487 0.016 0.014 DBMET01488 0.016 0.014 DBMET01489 0.016 0.014 DBMET01490 0.046 0.001 DBMET01491 | DBMET01491 | |
| 0.039 | 0.053 | 0.062 | Beta 2 adrenoreceptor antagonist | 0.062 0.023 DBMET01491 | DBMET01491 | |
| 0.074 | 0.089 | 0.141 | Estrogen-related receptor beta agonist | 0.079 0.071 DBMET01486 0.079 0.071 DBMET01487 0.079 0.071 DBMET01488 0.079 0.071 DBMET01489 0.079 0.071 DBMET01490 0.141 0.005 DBMET01491 | DBMET01491 | |
| 0.024 | 0.039 | 0.057 | ATP citrate lysase inhibitor | 0.057 0.005 DBMET01491 | DBMET01491 | |
| 0.008 | 0.023 | 0.015 | Purine nucleoside phosphorylase inhibitor | 0.015 0.004 DBMET01491 | DBMET01491 | |
| 0.004 | 0.02 | 0.007 | Integrin alpha5beta6 antagonist | 0.007 0.004 DBMET01491 | DBMET01491 | |
| 0.021 | 0.037 | 0.027 | Complement factor 1s inhibitor | 0.027 0.013 DBMET01491 | DBMET01491 | |
| 0.005 | 0.022 | 0.019 | Antibiotic Macrolide-like | 0.019 0.007 DBMET01491 | DBMET01491 | |
| 0.029 | 0.046 | 0.041 | Glutamate (mGluR group II) antagonist | 0.041 0.024 DBMET01491 | DBMET01491 | |
| 0.014 | 0.032 | 0.038 | Purinergic P2Y12 antagonist | 0.038 0.009 DBMET01491 | DBMET01491 | |
| 0.097 | 0.116 | 0.15 | Transcription factor STAT6 inhibitor | 0.15 0.023 DBMET01491 | DBMET01491 | |
| 0.035 | 0.053 | 0.053 | CF transmembrane conductance regulator antagonist | 0.053 0.007 DBMET01491 | DBMET01491 | |
| 0.06 | 0.079 | 0.113 | Adenosine A3 receptor antagonist | 0.113 0.02 DBMET01491 | DBMET01491 | |
| 0.109 | 0.127 | 0.144 | Anticoagulant | 0.121 0.11 DBMET01486 0.121 0.11 DBMET01487 0.121 0.11 DBMET01488 0.121 0.11 DBMET01489 0.121 0.11 DBMET01490 0.144 0.086 DBMET01491 | DBMET01491 | |
| 0.01 | 0.029 | 0.031 | Carbonic anhydrase VIII inhibitor | 0.031 0.004 DBMET01491 | DBMET01491 | |
| 0.01 | 0.029 | 0.031 | Carbonic anhydrase X inhibitor | 0.031 0.004 DBMET01491 | DBMET01491 | |
| 0.037 | 0.056 | 0.055 | Purinergic P2X4 antagonist | 0.055 0.019 DBMET01491 | DBMET01491 | |
| 0.023 | 0.042 | 0.047 | Cholesterol ester transfer protein antagonist | 0.047 0.009 DBMET01491 | DBMET01491 | |
| 0.022 | 0.041 | 0.028 | Glutamate (mGluR2) antagonist | 0.028 0.024 DBMET01491 | DBMET01491 | |
| 0.079 | 0.099 | 0.105 | Nitric-oxide synthase inhibitor | 0.105 0.053 DBMET01491 | DBMET01491 | |
| 0.01 | 0.03 | 0.013 | Cyclin D2 inhibitor | 0.013 0.01 DBMET01491 | DBMET01491 | |
| 0.027 | 0.047 | 0.036 | Retinoid X alpha receptor antagonist | 0.036 0.02 DBMET01491 | DBMET01491 | |
| 0.073 | 0.093 | 0.086 | Pim-3 kinase inhibitor | 0.086 0.065 DBMET01491 | DBMET01491 | |
| 0.028 | 0.049 | 0.052 | Dihydropteroate synthase inhibitor | 0.052 0.016 DBMET01491 | DBMET01491 | |
| 0.029 | 0.05 | 0.041 | Retinoid X receptor antagonist | 0.041 0.022 DBMET01491 | DBMET01491 | |
| 0.033 | 0.055 | 0.259 | Mannosidase inhibitor | 0.055 0.02 DBMET01486 0.055 0.02 DBMET01487 0.055 0.02 DBMET01488 0.055 0.02 DBMET01489 0.055 0.02 DBMET01490 0.259 0.002 DBMET01491 | DBMET01491 | |
| 0.006 | 0.028 | 0.032 | Glutamate (mGluR6) agonist | 0.032 0.003 DBMET01491 | DBMET01491 | |
| 0.011 | 0.032 | 0.032 | Purinergic P2Y1 agonist | 0.032 0.003 DBMET01491 | DBMET01491 | |
| 0.034 | 0.056 | 0.081 | AICAR transformylase inhibitor | 0.081 0.007 DBMET01491 | DBMET01491 | |
| 0.02 | 0.042 | 0.081 | Sodium/glucose cotransporter inhibitor | 0.028 0.014 DBMET01486 0.028 0.014 DBMET01487 0.028 0.014 DBMET01488 0.028 0.014 DBMET01489 0.028 0.014 DBMET01490 0.081 0.003 DBMET01491 | DBMET01491 | |
| 0.03 | 0.052 | 0.081 | Purinergic P2Y antagonist | 0.042 0.034 DBMET01486 0.042 0.034 DBMET01487 0.042 0.034 DBMET01488 0.042 0.034 DBMET01489 0.042 0.034 DBMET01490 0.081 0.013 DBMET01491 | DBMET01491 | |
| 0.014 | 0.036 | 0.038 | Antibiotic Anthracycline-like | 0.038 0.002 DBMET01491 | DBMET01491 | |
| 0.045 | 0.068 | 0.061 | Sphingosine 1-phosphate receptor 3 antagonist | 0.061 0.037 DBMET01491 | DBMET01491 | |
| 0.025 | 0.048 | 0.065 | HMG CoA reductase inhibitor | 0.032 0.028 DBMET01486 0.032 0.028 DBMET01487 0.032 0.028 DBMET01488 0.032 0.028 DBMET01489 0.032 0.028 DBMET01490 0.065 0.004 DBMET01491 | DBMET01491 | |
| 0.01 | 0.033 | 0.04 | Thromboxane A2 agonist | 0.04 0.002 DBMET01491 | DBMET01491 | |
| 0.053 | 0.076 | 0.186 | Catalase inhibitor | 0.186 0.018 DBMET01491 | DBMET01491 | |
| 0.014 | 0.038 | 0.071 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.071 0.005 DBMET01491 | DBMET01491 | |
| 0.051 | 0.075 | 0.075 | Aryl hydrocarbon receptor antagonist | 0.075 0.031 DBMET01491 | DBMET01491 | |
| 0.037 | 0.06 | 0.093 | Carbonic anhydrase VB inhibitor | 0.093 0.018 DBMET01491 | DBMET01491 | |
| 0.014 | 0.038 | 0.033 | Glutamate (mGluR1a) agonist | 0.033 0.007 DBMET01491 | DBMET01491 | |
| 0.015 | 0.04 | 0.033 | Neuraminidase (Influenza B) inhibitor | 0.033 0.004 DBMET01491 | DBMET01491 | |
| 0.076 | 0.102 | 0.113 | Interleukin 1 beta converting enzyme inhibitor | 0.113 0.042 DBMET01491 | DBMET01491 | |
| 0.039 | 0.065 | 0.056 | Dopamine uptake inhibitor | 0.056 0.042 DBMET01491 | DBMET01491 | |
| 0.016 | 0.042 | 0.04 | Isoleucine-tRNA ligase inhibitor | 0.04 0.003 DBMET01491 | DBMET01491 | |
| 0.072 | 0.098 | 0.124 | D-Ala-D-Ala ligase inhibitor | 0.124 0.012 DBMET01491 | DBMET01491 | |
| 0.03 | 0.058 | 0.045 | Histamine H2 receptor agonist | 0.045 0.027 DBMET01491 | DBMET01491 | |
| 0.026 | 0.053 | 0.072 | Ceramide glucosyltransferase inhibitor | 0.038 0.021 DBMET01486 0.038 0.021 DBMET01487 0.038 0.021 DBMET01488 0.038 0.021 DBMET01489 0.038 0.021 DBMET01490 0.072 0.003 DBMET01491 | DBMET01491 | |
| 0.011 | 0.039 | 0.049 | Prostaglandin EP2 agonist | 0.049 0.006 DBMET01491 | DBMET01491 | |
| 0.116 | 0.144 | 0.146 | CC chemokine 6 receptor antagonist | 0.128 0.078 DBMET01486 0.128 0.078 DBMET01487 0.128 0.078 DBMET01488 0.128 0.078 DBMET01489 0.128 0.078 DBMET01490 0.146 0.028 DBMET01491 | DBMET01491 | |
| 0.006 | 0.034 | 0.025 | Lysophosphatidic acid receptor 3 agonist | 0.025 0.004 DBMET01491 | DBMET01491 | |
| 0.045 | 0.074 | 0.147 | HIV-1 integrase (3'-Processing) inhibitor | 0.065 0.042 DBMET01486 0.065 0.042 DBMET01487 0.065 0.042 DBMET01488 0.065 0.042 DBMET01489 0.065 0.042 DBMET01490 0.147 0.014 DBMET01491 | DBMET01491 | |
| 0.042 | 0.07 | 0.159 | Neuraminidase inhibitor | 0.058 0.046 DBMET01486 0.058 0.046 DBMET01487 0.058 0.046 DBMET01488 0.058 0.046 DBMET01489 0.058 0.046 DBMET01490 0.159 0.005 DBMET01491 | DBMET01491 | |
| 0.064 | 0.093 | 0.122 | GABA B receptor agonist | 0.122 0.007 DBMET01491 | DBMET01491 | |
| 0.017 | 0.046 | 0.095 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.016 DBMET01486 0.027 0.016 DBMET01487 0.027 0.016 DBMET01488 0.027 0.016 DBMET01489 0.027 0.016 DBMET01490 0.095 0.003 DBMET01491 | DBMET01491 | |
| 0.025 | 0.054 | 0.032 | Carboxypeptidase B inhibitor | 0.032 0.025 DBMET01491 | DBMET01491 | |
| 0.043 | 0.073 | 0.053 | MAP kinase kinase 9 inhibitor | 0.053 0.043 DBMET01491 | DBMET01491 | |
| 0.065 | 0.095 | 0.111 | Glutathione S-transferase inhibitor | 0.111 0.029 DBMET01491 | DBMET01491 | |
| 0.011 | 0.041 | 0.042 | Adenosine kinase inhibitor | 0.042 0.007 DBMET01491 | DBMET01491 | |
| 0.124 | 0.154 | 0.373 | Lipocortins synthesis antagonist | 0.173 0.078 DBMET01486 0.173 0.078 DBMET01487 0.173 0.078 DBMET01488 0.173 0.078 DBMET01489 0.173 0.078 DBMET01490 0.373 0.011 DBMET01491 | DBMET01491 | |
| 0.007 | 0.038 | 0.013 | Integrin alphaVbeta6 antagonist | 0.013 0.012 DBMET01491 | DBMET01491 | |
| 0.047 | 0.078 | 0.067 | Immunoglobulin Fc receptor antagonist | 0.067 0.014 DBMET01491 | DBMET01491 | |
| 0.019 | 0.051 | 0.034 | Kainate receptor 2 antagonist | 0.034 0.027 DBMET01491 | DBMET01491 | |
| 0.001 | 0.034 | 0.008 | Transcortin receptor antagonist | 0.008 0.003 DBMET01491 | DBMET01491 | |
| 0.013 | 0.046 | 0.051 | Purinergic P2X agonist | 0.051 0.009 DBMET01491 | DBMET01491 | |
| 0.037 | 0.071 | 0.068 | Beta 1 adrenoreceptor antagonist | 0.068 0.028 DBMET01491 | DBMET01491 | |
| 0.017 | 0.05 | 0.08 | Arginase inhibitor | 0.08 0.006 DBMET01491 | DBMET01491 | |
| 0.015 | 0.048 | 0.039 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.039 0.003 DBMET01491 | DBMET01491 | |
| 0.004 | 0.038 | 0.029 | Thromboxane agonist | 0.029 0.003 DBMET01491 | DBMET01491 | |
| 0.047 | 0.082 | 0.061 | Leukotriene C antagonist | 0.061 0.027 DBMET01491 | DBMET01491 | |
| 0.029 | 0.064 | 0.052 | Glucose-6-phosphate dehydrogenase inhibitor | 0.052 0.01 DBMET01491 | DBMET01491 | |
| 0.071 | 0.105 | 0.086 | Bromodomain-containing protein 2 inhibitor | 0.086 0.063 DBMET01491 | DBMET01491 | |
| 0.066 | 0.101 | 0.118 | MAP kinase kinase 7 inhibitor | 0.118 0.005 DBMET01491 | DBMET01491 | |
| 0.016 | 0.052 | 0.036 | Lysophosphatidic acid receptor 1 agonist | 0.036 0.007 DBMET01491 | DBMET01491 | |
| 0.041 | 0.077 | 0.07 | Carbonic anhydrase stimulant | 0.07 0.032 DBMET01491 | DBMET01491 | |
| 0.015 | 0.051 | 0.035 | Lysine carboxypeptidase inhibitor | 0.035 0.013 DBMET01491 | DBMET01491 | |
| 0.017 | 0.053 | 0.064 | Prostaglandin agonist | 0.064 0.008 DBMET01491 | DBMET01491 | |
| 0.05 | 0.087 | 0.143 | Interferon inducer | 0.062 0.048 DBMET01486 0.062 0.048 DBMET01487 0.062 0.048 DBMET01488 0.062 0.048 DBMET01489 0.062 0.048 DBMET01490 0.143 0.005 DBMET01491 | DBMET01491 | |
| 0.069 | 0.106 | 0.196 | Sphingomyelinase inhibitor | 0.196 0.01 DBMET01491 | DBMET01491 | |
| 0.017 | 0.054 | 0.028 | LFA antagonist | 0.028 0.019 DBMET01491 | DBMET01491 | |
| 0.048 | 0.085 | 0.115 | Carbonic anhydrase VA inhibitor | 0.115 0.019 DBMET01491 | DBMET01491 | |
| 0.014 | 0.051 | 0.059 | Prostaglandin F2 alpha agonist | 0.059 0.004 DBMET01491 | DBMET01491 | |
| 0.037 | 0.074 | 0.055 | Bombesin 2 receptor antagonist | 0.055 0.028 DBMET01491 | DBMET01491 | |
| 0.01 | 0.048 | 0.022 | Vitamin D receptor agonist | 0.022 0.005 DBMET01491 | DBMET01491 | |
| 0.004 | 0.042 | 0.015 | Purinergic P2Y agonist | 0.015 0.007 DBMET01491 | DBMET01491 | |
| 0.006 | 0.045 | 0.028 | Adenosine A2a receptor agonist | 0.028 0.006 DBMET01491 | DBMET01491 | |
| 0.032 | 0.071 | 0.053 | GABA B receptor antagonist | 0.053 0.017 DBMET01491 | DBMET01491 | |
| 0.019 | 0.058 | 0.034 | Calcitonin receptor agonist | 0.034 0.023 DBMET01491 | DBMET01491 | |
| 0.017 | 0.057 | 0.027 | Glutamate (mGluR1) agonist | 0.027 0.013 DBMET01491 | DBMET01491 | |
| 0.007 | 0.047 | 0.048 | Ileal bile acid transport inhibitor | 0.048 0.004 DBMET01491 | DBMET01491 | |
| 0.037 | 0.077 | 0.12 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.12 0.007 DBMET01491 | DBMET01491 | |
| 0.024 | 0.064 | 0.055 | Glutamate (mGluR3) agonist | 0.055 0.004 DBMET01491 | DBMET01491 | |
| 0.004 | 0.044 | 0.02 | Purinergic receptor agonist | 0.02 0.007 DBMET01491 | DBMET01491 | |
| 0.004 | 0.044 | 0.02 | Purinergic P2 agonist | 0.02 0.007 DBMET01491 | DBMET01491 | |
| 0.044 | 0.085 | 0.115 | Sphingosine kinase inhibitor | 0.115 0.005 DBMET01491 | DBMET01491 | |
| 0.041 | 0.082 | 0.179 | Glucosylceramidase inhibitor | 0.065 0.026 DBMET01486 0.065 0.026 DBMET01487 0.065 0.026 DBMET01488 0.065 0.026 DBMET01489 0.065 0.026 DBMET01490 0.179 0.003 DBMET01491 | DBMET01491 | |
| 0.031 | 0.073 | 0.12 | Adenylate cyclase 1 inhibitor | 0.12 0.003 DBMET01491 | DBMET01491 | |
| 0.033 | 0.075 | 0.056 | Alpha tubulin antagonist | 0.056 0.034 DBMET01491 | DBMET01491 | |
| 0.002 | 0.044 | 0.008 | Mannitol 2-dehydrogenase inhibitor | 0.008 0.006 DBMET01491 | DBMET01491 | |
| 0.017 | 0.06 | 0.033 | Integrin alpha2beta1 antagonist | 0.033 0.01 DBMET01491 | DBMET01491 | |
| 0.156 | 0.199 | 0.208 | 12-Lipoxygenase inhibitor | 0.208 0.143 DBMET01491 | DBMET01491 | |
| 0.009 | 0.052 | 0.022 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.022 0.012 DBMET01491 | DBMET01491 | |
| 0.041 | 0.085 | 0.08 | Dihydroorotate oxidase inhibitor | 0.08 0.01 DBMET01491 | DBMET01491 | |
| 0.045 | 0.088 | 0.066 | 5 Hydroxytryptamine 3 agonist | 0.066 0.04 DBMET01491 | DBMET01491 | |
| 0.067 | 0.112 | 0.109 | Interleukin 5 antagonist | 0.109 0.032 DBMET01491 | DBMET01491 | |
| 0.025 | 0.069 | 0.058 | Delayed rectifier potassium channel blocker | 0.058 0.008 DBMET01491 | DBMET01491 | |
| 0.011 | 0.056 | 0.038 | Corticosteroid-like | 0.038 0.004 DBMET01491 | DBMET01491 | |
| 0.086 | 0.132 | 0.204 | Toll-Like receptor 2 antagonist | 0.204 0.022 DBMET01491 | DBMET01491 | |
| 0.073 | 0.12 | 0.277 | Adenylate cyclase inhibitor | 0.099 0.085 DBMET01486 0.099 0.085 DBMET01487 0.099 0.085 DBMET01488 0.099 0.085 DBMET01489 0.099 0.085 DBMET01490 0.277 0.016 DBMET01491 | DBMET01491 | |
| 0.019 | 0.066 | 0.04 | Kainate receptor antagonist | 0.04 0.029 DBMET01491 | DBMET01491 | |
| 0.036 | 0.083 | 0.063 | Leukotriene B4 antagonist | 0.063 0.025 DBMET01491 | DBMET01491 | |
| 0.067 | 0.115 | 0.128 | mTOR complex 2 inhibitor | 0.128 0.014 DBMET01491 | DBMET01491 | |
| 0.018 | 0.066 | 0.045 | Thymidine phosphorylase inhibitor | 0.045 0.005 DBMET01491 | DBMET01491 | |
| 0.059 | 0.108 | 0.123 | Vanilloid 4 agonist | 0.123 0.006 DBMET01491 | DBMET01491 | |
| 0.099 | 0.148 | 0.143 | Phospholipase A2 inhibitor | 0.143 0.082 DBMET01491 | DBMET01491 | |
| 0.103 | 0.154 | 0.392 | Amyloid beta aggregation inhibitor | 0.186 0.086 DBMET01486 0.186 0.086 DBMET01487 0.186 0.086 DBMET01488 0.186 0.086 DBMET01489 0.186 0.086 DBMET01490 0.392 0.026 DBMET01491 | DBMET01491 | |
| 0.03 | 0.08 | 0.04 | Leukotriene C4 antagonist | 0.04 0.025 DBMET01491 | DBMET01491 | |
| 0.009 | 0.059 | 0.038 | Prostaglandin E2 agonist | 0.038 0.008 DBMET01491 | DBMET01491 | |
| 0.049 | 0.1 | 0.068 | Epoxide hydrolase inhibitor | 0.068 0.055 DBMET01491 | DBMET01491 | |
| 0.113 | 0.164 | 0.237 | Interleukin antagonist | 0.134 0.131 DBMET01486 0.134 0.131 DBMET01487 0.134 0.131 DBMET01488 0.134 0.131 DBMET01489 0.134 0.131 DBMET01490 0.237 0.067 DBMET01491 | DBMET01491 | |
| 0.024 | 0.076 | 0.057 | Membrane dipeptidase inhibitor | 0.057 0.011 DBMET01491 | DBMET01491 | |
| 0.148 | 0.2 | 0.471 | Peptidyltransferase inhibitor | 0.25 0.051 DBMET01486 0.25 0.051 DBMET01487 0.25 0.051 DBMET01488 0.25 0.051 DBMET01489 0.25 0.051 DBMET01490 0.471 0.004 DBMET01491 | DBMET01491 | |
| 0.035 | 0.087 | 0.062 | Acetylcholine M3 receptor antagonist | 0.062 0.039 DBMET01491 | DBMET01491 | |
| 0.043 | 0.096 | 0.076 | Adenine nucleotide translocase inhibitor | 0.052 0.049 DBMET01486 0.052 0.049 DBMET01487 0.052 0.049 DBMET01488 0.052 0.049 DBMET01489 0.052 0.049 DBMET01490 0.076 0.011 DBMET01491 | DBMET01491 | |
| 0.012 | 0.066 | 0.04 | Acetylcholine M4 receptor agonist | 0.04 0.015 DBMET01491 | DBMET01491 | |
| 0.112 | 0.166 | 0.349 | Interleukin 6 antagonist | 0.147 0.094 DBMET01486 0.147 0.094 DBMET01487 0.147 0.094 DBMET01488 0.147 0.094 DBMET01489 0.147 0.094 DBMET01490 0.349 0.01 DBMET01491 | DBMET01491 | |
| 0.093 | 0.146 | 0.146 | Sphingosine 1-phosphate receptor 4 antagonist | 0.146 0.037 DBMET01491 | DBMET01491 | |
| 0.01 | 0.064 | 0.018 | 5-Alpha-reductase 2 inhibitor | 0.018 0.015 DBMET01491 | DBMET01491 | |
| 0.031 | 0.085 | 0.057 | Potassium channel (Inward rectifier) blocker | 0.057 0.026 DBMET01491 | DBMET01491 | |
| 0.039 | 0.094 | 0.124 | Carbonic anhydrase V inhibitor | 0.124 0.02 DBMET01491 | DBMET01491 | |
| 0.052 | 0.107 | 0.163 | GABA aminotransferase inhibitor | 0.163 0.006 DBMET01491 | DBMET01491 | |
| 0.043 | 0.098 | 0.077 | Beta adrenoreceptor antagonist | 0.077 0.03 DBMET01491 | DBMET01491 | |
| 0.007 | 0.063 | 0.025 | Adenosine A2 receptor agonist | 0.025 0.006 DBMET01491 | DBMET01491 | |
| 0.027 | 0.084 | 0.046 | Plasmepsin II inhibitor | 0.046 0.021 DBMET01491 | DBMET01491 | |
| 0.069 | 0.126 | 0.132 | MAP kinase kinase 1 inhibitor | 0.132 0.025 DBMET01491 | DBMET01491 | |
| 0.04 | 0.097 | 0.072 | Leukotriene antagonist | 0.072 0.038 DBMET01491 | DBMET01491 | |
| 0.055 | 0.112 | 0.193 | Interferon agonist | 0.072 0.066 DBMET01486 0.072 0.066 DBMET01487 0.072 0.066 DBMET01488 0.072 0.066 DBMET01489 0.072 0.066 DBMET01490 0.193 0.006 DBMET01491 | DBMET01491 | |
| 0.036 | 0.094 | 0.13 | Androgen agonist | 0.13 0.009 DBMET01491 | DBMET01491 | |
| 0.172 | 0.23 | 0.442 | Sodium/bile acid cotransporter inhibitor | 0.282 0.096 DBMET01486 0.282 0.096 DBMET01487 0.282 0.096 DBMET01488 0.282 0.096 DBMET01489 0.282 0.096 DBMET01490 0.442 0.009 DBMET01491 | DBMET01491 | |
| 0.025 | 0.083 | 0.073 | Potassium channel Kv1.3 blocker | 0.073 0.014 DBMET01491 | DBMET01491 | |
| 0.007 | 0.066 | 0.021 | Alpha 2a adrenoreceptor agonist | 0.021 0.009 DBMET01491 | DBMET01491 | |
| 0.044 | 0.104 | 0.075 | Protease 3C (Human rhinovirus) inhibitor | 0.075 0.032 DBMET01491 | DBMET01491 | |
| 0.019 | 0.08 | 0.057 | Inosine monophosphate dehydrogenase inhibitor | 0.057 0.012 DBMET01491 | DBMET01491 | |
| 0.035 | 0.096 | 0.061 | Acetylcholine M5 receptor antagonist | 0.061 0.041 DBMET01491 | DBMET01491 | |
| 0.05 | 0.111 | 0.075 | Beta 2 adrenoreceptor agonist | 0.075 0.013 DBMET01491 | DBMET01491 | |
| 0.005 | 0.067 | 0.013 | Carbonic anhydrase XI inhibitor | 0.013 0.008 DBMET01491 | DBMET01491 | |
| 0.051 | 0.114 | 0.09 | Calcium channel P-type blocker | 0.09 0.009 DBMET01491 | DBMET01491 | |
| 0.022 | 0.085 | 0.044 | Integrin alpha2 antagonist | 0.044 0.016 DBMET01491 | DBMET01491 | |
| 0.13 | 0.193 | 0.225 | Growth factor agonist | 0.155 0.131 DBMET01486 0.155 0.131 DBMET01487 0.155 0.131 DBMET01488 0.155 0.131 DBMET01489 0.155 0.131 DBMET01490 0.225 0.044 DBMET01491 | DBMET01491 | |
| 0.026 | 0.091 | 0.045 | Dihydroorotase inhibitor | 0.045 0.03 DBMET01491 | DBMET01491 | |
| 0.021 | 0.088 | 0.063 | GABA uptake inhibitor | 0.063 0.009 DBMET01491 | DBMET01491 | |
| 0.002 | 0.07 | 0.01 | DNA topoisomerase III inhibitor | 0.01 0.004 DBMET01491 | DBMET01491 | |
| 0.02 | 0.088 | 0.036 | RNA-directed RNA polymerase inhibitor | 0.036 0.022 DBMET01491 | DBMET01491 | |
| 0.128 | 0.196 | 0.185 | Histone acetyltransferase inhibitor | 0.185 0.092 DBMET01491 | DBMET01491 | |
| 0.035 | 0.105 | 0.073 | Cyclin D1 inhibitor | 0.073 0.024 DBMET01491 | DBMET01491 | |
| 0.025 | 0.096 | 0.084 | Sphingosine kinase 1 inhibitor | 0.084 0.005 DBMET01491 | DBMET01491 | |
| 0.003 | 0.075 | 0.04 | Prostaglandin EP4 agonist | 0.04 0.006 DBMET01491 | DBMET01491 | |
| 0.012 | 0.084 | 0.032 | HCV NS5B polymerase inhibitor | 0.032 0.02 DBMET01491 | DBMET01491 | |
| 0.013 | 0.085 | 0.044 | 5-Alpha-reductase inhibitor | 0.044 0.021 DBMET01491 | DBMET01491 | |
| 0.036 | 0.108 | 0.064 | Epithelial sodium channel blocker | 0.064 0.024 DBMET01491 | DBMET01491 | |
| 0.039 | 0.112 | 0.136 | Prostaglandin F2 alpha antagonist | 0.136 0.005 DBMET01491 | DBMET01491 | |
| 0.011 | 0.084 | 0.028 | Prostaglandin EP4 antagonist | 0.028 0.017 DBMET01491 | DBMET01491 | |
| 0.027 | 0.101 | 0.068 | Carbonic anhydrase inhibitor | 0.068 0.041 DBMET01491 | DBMET01491 | |
| 0.02 | 0.095 | 0.05 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.05 0.011 DBMET01491 | DBMET01491 | |
| 0.034 | 0.111 | 0.329 | Antineoplastic antibiotic | 0.075 0.061 DBMET01486 0.075 0.061 DBMET01487 0.075 0.061 DBMET01488 0.075 0.061 DBMET01489 0.075 0.061 DBMET01490 0.329 0.008 DBMET01491 | DBMET01491 | |
| 0.015 | 0.092 | 0.042 | Vitamin D receptor antagonist | 0.042 0.005 DBMET01491 | DBMET01491 | |
| 0.019 | 0.097 | 0.099 | Dopamine D5 agonist | 0.099 0.004 DBMET01491 | DBMET01491 | |
| 0.022 | 0.1 | 0.07 | Thymidylate synthase inhibitor | 0.07 0.012 DBMET01491 | DBMET01491 | |
| 0.004 | 0.084 | 0.019 | Kainate receptor 1 antagonist | 0.019 0.016 DBMET01491 | DBMET01491 | |
| 0.007 | 0.087 | 0.05 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.05 0.004 DBMET01491 | DBMET01491 | |
| 0.043 | 0.123 | 0.106 | Lipocortins synthesis agonist | 0.058 0.041 DBMET01486 0.058 0.041 DBMET01487 0.058 0.041 DBMET01488 0.058 0.041 DBMET01489 0.058 0.041 DBMET01490 0.106 0.004 DBMET01491 | DBMET01491 | |
| 0.044 | 0.124 | 0.059 | Phosphodiesterase 1C inhibitor | 0.059 0.051 DBMET01491 | DBMET01491 | |
| 0.036 | 0.116 | 0.053 | Factor III inhibitor | 0.053 0.027 DBMET01491 | DBMET01491 | |
| 0.018 | 0.099 | 0.061 | Oxytocin agonist | 0.061 0.016 DBMET01491 | DBMET01491 | |
| 0.013 | 0.094 | 0.032 | Potassium channel small-conductance Ca-activated activator | 0.032 0.021 DBMET01491 | DBMET01491 | |
| 0.167 | 0.25 | 0.25 | 15-Lipoxygenase inhibitor | 0.25 0.164 DBMET01491 | DBMET01491 | |
| 0.033 | 0.116 | 0.125 | Sphingosine kinase 2 inhibitor | 0.125 0.004 DBMET01491 | DBMET01491 | |
| 0.008 | 0.091 | 0.036 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.036 0.01 DBMET01491 | DBMET01491 | |
| 0.093 | 0.177 | 0.179 | Vanilloid 1 agonist | 0.179 0.019 DBMET01491 | DBMET01491 | |
| 0.019 | 0.103 | 0.059 | Carbonic anhydrase II inhibitor | 0.059 0.036 DBMET01491 | DBMET01491 | |
| 0.015 | 0.101 | 0.04 | Vascular adhesion protein 1 inhibitor | 0.04 0.026 DBMET01491 | DBMET01491 | |
| 0.027 | 0.113 | 0.048 | Diacylglycerol O-acyltransferase inhibitor | 0.048 0.038 DBMET01491 | DBMET01491 | |
| 0.058 | 0.144 | 0.092 | Phosphodiesterase I inhibitor | 0.092 0.056 DBMET01491 | DBMET01491 | |
| 0.059 | 0.147 | 0.277 | Topoisomerase II inhibitor | 0.104 0.083 DBMET01486 0.104 0.083 DBMET01487 0.104 0.083 DBMET01488 0.104 0.083 DBMET01489 0.104 0.083 DBMET01490 0.277 0.021 DBMET01491 | DBMET01491 | |
| 0.118 | 0.207 | 0.195 | Neurotensin receptor agonist | 0.195 0.037 DBMET01491 | DBMET01491 | |
| 0.051 | 0.14 | 0.121 | Urease inhibitor | 0.121 0.044 DBMET01491 | DBMET01491 | |
| 0.093 | 0.183 | 0.165 | Sphingosine 1-phosphate receptor 2 antagonist | 0.165 0.025 DBMET01491 | DBMET01491 | |
| 0.086 | 0.177 | 0.201 | Diuretic | 0.201 0.044 DBMET01491 | DBMET01491 | |
| 0.021 | 0.112 | 0.036 | MAP3K5 inhibitor | 0.036 0.033 DBMET01491 | DBMET01491 | |
| 0.043 | 0.136 | 0.137 | Androgen antagonist | 0.137 0.026 DBMET01491 | DBMET01491 | |
| 0.068 | 0.161 | 0.144 | Bone formation stimulant | 0.144 0.064 DBMET01491 | DBMET01491 | |
| 0.002 | 0.098 | 0.009 | Progesterone receptor A antagonist | 0.009 0.007 DBMET01491 | DBMET01491 | |
| 0.003 | 0.099 | 0.033 | Glucocorticoid agonist | 0.033 0.005 DBMET01491 | DBMET01491 | |
| 0.013 | 0.11 | 0.041 | 1,3-Beta-glucan synthase inhibitor | 0.041 0.004 DBMET01491 | DBMET01491 | |
| 0.051 | 0.15 | 0.102 | Protease inhibitor | 0.102 0.064 DBMET01491 | DBMET01491 | |
| 0.005 | 0.104 | 0.017 | NMDA receptor phencyclidine site antagonist | 0.017 0.009 DBMET01491 | DBMET01491 | |
| 0.021 | 0.122 | 0.062 | Acetylcholine muscarinic agonist | 0.062 0.032 DBMET01491 | DBMET01491 | |
| 0.121 | 0.221 | 0.162 | Calpain inhibitor | 0.162 0.16 DBMET01491 | DBMET01491 | |
| 0.031 | 0.132 | 0.092 | Sphingosine 1-phosphate receptor 4 agonist | 0.092 0.029 DBMET01491 | DBMET01491 | |
| 0.012 | 0.113 | 0.051 | Carbonic anhydrase XII inhibitor | 0.051 0.038 DBMET01491 | DBMET01491 | |
| 0.033 | 0.134 | 0.051 | CD45 antagonist | 0.051 0.034 DBMET01491 | DBMET01491 | |
| 0.021 | 0.123 | 0.116 | Antibiotic Aminoglycoside-like | 0.041 0.02 DBMET01486 0.041 0.02 DBMET01487 0.041 0.02 DBMET01488 0.041 0.02 DBMET01489 0.041 0.02 DBMET01490 0.116 0.002 DBMET01491 | DBMET01491 | |
| 0.02 | 0.125 | 0.044 | Liver X receptor alpha agonist | 0.044 0.025 DBMET01491 | DBMET01491 | |
| 0.046 | 0.153 | 0.083 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.083 0.067 DBMET01491 | DBMET01491 | |
| 0.051 | 0.16 | 0.103 | Estrogen receptor alpha antagonist | 0.103 0.025 DBMET01491 | DBMET01491 | |
| 0.019 | 0.128 | 0.084 | Adenosine A1 receptor antagonist | 0.084 0.027 DBMET01491 | DBMET01491 | |
| 0.01 | 0.119 | 0.054 | Carbonic anhydrase IX inhibitor | 0.054 0.04 DBMET01491 | DBMET01491 | |
| 0.034 | 0.143 | 0.088 | NMDA receptor agonist | 0.088 0.024 DBMET01491 | DBMET01491 | |
| 0.045 | 0.156 | 0.41 | Topoisomerase I inhibitor | 0.128 0.051 DBMET01486 0.128 0.051 DBMET01487 0.128 0.051 DBMET01488 0.128 0.051 DBMET01489 0.128 0.051 DBMET01490 0.41 0.005 DBMET01491 | DBMET01491 | |
| 0.042 | 0.153 | 0.113 | HIV-1 integrase inhibitor | 0.113 0.018 DBMET01491 | DBMET01491 | |
| 0.126 | 0.238 | 0.189 | Lipoxygenase inhibitor | 0.189 0.152 DBMET01491 | DBMET01491 | |
| 0.055 | 0.17 | 0.162 | 5 Hydroxytryptamine 3A agonist | 0.162 0.029 DBMET01491 | DBMET01491 | |
| 0.032 | 0.147 | 0.055 | 5 Hydroxytryptamine 7 agonist | 0.055 0.041 DBMET01491 | DBMET01491 | |
| 0.021 | 0.137 | 0.036 | 5 Hydroxytryptamine 2B agonist | 0.036 0.033 DBMET01491 | DBMET01491 | |
| 0.022 | 0.138 | 0.053 | Maillard reaction inhibitor | 0.053 0.04 DBMET01491 | DBMET01491 | |
| 0.015 | 0.132 | 0.038 | Sphingosine 1-phosphate receptor 1 agonist | 0.038 0.037 DBMET01491 | DBMET01491 | |
| 0.062 | 0.18 | 0.124 | Caspase 3 inhibitor | 0.124 0.054 DBMET01491 | DBMET01491 | |
| 0.012 | 0.133 | 0.047 | Acetylcholine M1 receptor agonist | 0.047 0.027 DBMET01491 | DBMET01491 | |
| 0.096 | 0.217 | 0.17 | Sphingosine 1-phosphate receptor 5 antagonist | 0.17 0.033 DBMET01491 | DBMET01491 | |
| 0.013 | 0.136 | 0.057 | Carbonic anhydrase I inhibitor | 0.057 0.037 DBMET01491 | DBMET01491 | |
| 0.038 | 0.162 | 0.163 | Potassium channel (Ca-activated) activator | 0.163 0.024 DBMET01491 | DBMET01491 | |
| 0.009 | 0.133 | 0.052 | Carbonic anhydrase IV inhibitor | 0.052 0.023 DBMET01491 | DBMET01491 | |
| 0.04 | 0.166 | 0.112 | Myeloperoxidase inhibitor | 0.112 0.024 DBMET01491 | DBMET01491 | |
| 0.09 | 0.216 | 0.219 | MAP kinase kinase 2 inhibitor | 0.219 0.07 DBMET01491 | DBMET01491 | |
| 0.05 | 0.177 | 0.12 | DNA intercalator | 0.12 0.058 DBMET01491 | DBMET01491 | |
| 0.135 | 0.266 | 0.209 | Neuropeptide Y2 antagonist | 0.209 0.104 DBMET01491 | DBMET01491 | |
| 0.011 | 0.142 | 0.033 | Catechol O-methyltransferase inhibitor | 0.033 0.022 DBMET01491 | DBMET01491 | |
| 0.021 | 0.152 | 0.086 | NMDA receptor glycine site agonist | 0.086 0.024 DBMET01491 | DBMET01491 | |
| 0.015 | 0.146 | 0.038 | Estrogen-related receptor gamma antagonist | 0.038 0.006 DBMET01491 | DBMET01491 | |
| 0.045 | 0.178 | 0.135 | M18 aspartyl aminopeptidase inhibitor | 0.135 0.06 DBMET01491 | DBMET01491 | |
| 0.01 | 0.143 | 0.035 | Plasmepsin I inhibitor | 0.035 0.016 DBMET01491 | DBMET01491 | |
| 0.009 | 0.142 | 0.04 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.04 0.016 DBMET01491 | DBMET01491 | |
| 0.008 | 0.142 | 0.022 | Dopamine D1 agonist | 0.022 0.016 DBMET01491 | DBMET01491 | |
| 0.034 | 0.17 | 0.066 | Corticotropin releasing factor 2 receptor antagonist | 0.066 0.034 DBMET01491 | DBMET01491 | |
| 0.006 | 0.141 | 0.055 | Squalene synthetase inhibitor | 0.055 0.013 DBMET01491 | DBMET01491 | |
| 0.014 | 0.151 | 0.067 | HIV-1 protease inhibitor | 0.067 0.009 DBMET01491 | DBMET01491 | |
| 0.011 | 0.151 | 0.062 | Estradiol 17 beta-dehydrogenase inhibitor | 0.062 0.019 DBMET01491 | DBMET01491 | |
| 0.037 | 0.177 | 0.069 | Metalloproteinase-9 inhibitor | 0.069 0.057 DBMET01491 | DBMET01491 | |
| 0.007 | 0.148 | 0.019 | Estrogen-related receptor gamma agonist | 0.019 0.013 DBMET01491 | DBMET01491 | |
| 0.023 | 0.168 | 0.056 | Alpha 2 adrenoreceptor agonist | 0.056 0.048 DBMET01491 | DBMET01491 | |
| 0.144 | 0.289 | 0.25 | Toll-Like receptor 7 agonist | 0.25 0.148 DBMET01491 | DBMET01491 | |
| 0.018 | 0.163 | 0.043 | AMPA 4 receptor antagonist | 0.043 0.022 DBMET01491 | DBMET01491 | |
| 0.079 | 0.226 | 0.121 | Thiol protease inhibitor | 0.121 0.115 DBMET01491 | DBMET01491 | |
| 0.099 | 0.25 | 0.161 | MAP kinase kinase 4 inhibitor | 0.161 0.044 DBMET01491 | DBMET01491 | |
| 0.059 | 0.211 | 0.103 | CC chemokine 5 receptor agonist | 0.103 0.019 DBMET01491 | DBMET01491 | |
| 0.004 | 0.163 | 0.054 | Prostacyclin agonist | 0.054 0.004 DBMET01491 | DBMET01491 | |
| 0.138 | 0.3 | 0.258 | Toll-Like receptor agonist | 0.258 0.141 DBMET01491 | DBMET01491 | |
| 0.035 | 0.197 | 0.077 | Beta 3 adrenoreceptor antagonist | 0.077 0.026 DBMET01491 | DBMET01491 | |
| 0.052 | 0.215 | 0.127 | MAP kinase kinase inhibitor | 0.127 0.068 DBMET01491 | DBMET01491 | |
| 0.017 | 0.18 | 0.061 | Adenosine A2 receptor antagonist | 0.061 0.048 DBMET01491 | DBMET01491 | |
| 0.009 | 0.174 | 0.261 | Estrogen agonist | 0.261 0.006 DBMET01491 | DBMET01491 | |
| 0.01 | 0.176 | 0.027 | Thyroid hormone agonist | 0.027 0.017 DBMET01491 | DBMET01491 | |
| 0.006 | 0.172 | 0.024 | CXC chemokine 2 receptor antagonist | 0.024 0.022 DBMET01491 | DBMET01491 | |
| 0.011 | 0.177 | 0.037 | Lysophosphatidic acid 2 receptor antagonist | 0.037 0.014 DBMET01491 | DBMET01491 | |
| 0.03 | 0.197 | 0.1 | Heat shock protein 90 beta antagonist | 0.1 0.011 DBMET01491 | DBMET01491 | |
| 0.04 | 0.21 | 0.071 | Sphingosine 1-phosphate receptor antagonist | 0.071 0.067 DBMET01491 | DBMET01491 | |
| 0.017 | 0.188 | 0.076 | Neuraminidase (Influenza A) inhibitor | 0.076 0.005 DBMET01491 | DBMET01491 | |
| 0.124 | 0.294 | 0.579 | Immunomodulator | 0.215 0.146 DBMET01486 0.215 0.146 DBMET01487 0.215 0.146 DBMET01488 0.215 0.146 DBMET01489 0.215 0.146 DBMET01490 0.579 0.014 DBMET01491 | DBMET01491 | |
| 0.009 | 0.181 | 0.051 | Carbonic anhydrase VII inhibitor | 0.051 0.026 DBMET01491 | DBMET01491 | |
| 0.019 | 0.193 | 0.034 | Glutamate (mGluR8) antagonist | 0.034 0.029 DBMET01491 | DBMET01491 | |
| 0.027 | 0.203 | 0.053 | Sphingosine 1-phosphate receptor 1 antagonist | 0.053 0.045 DBMET01491 | DBMET01491 | |
| 0.019 | 0.202 | 0.039 | Adenosine uptake inhibitor | 0.039 0.014 DBMET01491 | DBMET01491 | |
| 0.019 | 0.203 | 0.064 | 5 Hydroxytryptamine 2A agonist | 0.064 0.043 DBMET01491 | DBMET01491 | |
| 0.041 | 0.226 | 0.178 | Aminoacyl-tRNA synthetase inhibitor | 0.178 0.013 DBMET01491 | DBMET01491 | |
| 0.012 | 0.199 | 0.069 | NMDA 2C receptor antagonist | 0.069 0.034 DBMET01491 | DBMET01491 | |
| 0.012 | 0.2 | 0.07 | Adenosine A2a receptor antagonist | 0.07 0.036 DBMET01491 | DBMET01491 | |
| 0.009 | 0.2 | 0.046 | NMDA receptor subunit 3A antagonist | 0.046 0.022 DBMET01491 | DBMET01491 | |
| 0.014 | 0.206 | 0.054 | NMDA receptor subunit 3B antagonist | 0.054 0.022 DBMET01491 | DBMET01491 | |
| 0.006 | 0.198 | 0.041 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.041 0.005 DBMET01491 | DBMET01491 | |
| 0.013 | 0.209 | 0.107 | Aldose reductase inhibitor | 0.107 0.017 DBMET01491 | DBMET01491 | |
| 0.074 | 0.276 | 0.161 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.161 0.129 DBMET01491 | DBMET01491 | |
| 0.037 | 0.251 | 0.216 | Antineoplastic alkaloid | 0.216 0.01 DBMET01491 | DBMET01491 | |
| 0.025 | 0.239 | 0.07 | Cathepsin G inhibitor | 0.07 0.053 DBMET01491 | DBMET01491 | |
| 0.007 | 0.228 | 0.073 | Prostaglandin D2 agonist | 0.073 0.004 DBMET01491 | DBMET01491 | |
| 0.006 | 0.228 | 0.026 | Adenosine A3 receptor agonist | 0.026 0.006 DBMET01491 | DBMET01491 | |
| 0.008 | 0.23 | 0.107 | Protein 30S ribosomal subunit inhibitor | 0.107 0.003 DBMET01491 | DBMET01491 | |
| 0.01 | 0.234 | 0.085 | Opioid kappa receptor agonist | 0.085 0.012 DBMET01491 | DBMET01491 | |
| 0.006 | 0.233 | 0.017 | Adenosine A2b receptor agonist | 0.017 0.007 DBMET01491 | DBMET01491 | |
| 0.004 | 0.232 | 0.127 | Purinergic P2T antagonist | 0.127 0.004 DBMET01491 | DBMET01491 | |
| 0.006 | 0.242 | 0.031 | Leukotriene B4 receptor 2 antagonist | 0.031 0.008 DBMET01491 | DBMET01491 | |
| 0.023 | 0.264 | 0.186 | Topoisomerase II alpha inhibitor | 0.186 0.017 DBMET01491 | DBMET01491 | |
| 0.056 | 0.301 | 0.09 | Folate antagonist | 0.09 0.088 DBMET01491 | DBMET01491 | |
| 0.007 | 0.255 | 0.024 | CYP24 inhibitor | 0.024 0.014 DBMET01491 | DBMET01491 | |
| 0.004 | 0.254 | 0.025 | Leukotriene B4 receptor 1 antagonist | 0.025 0.022 DBMET01491 | DBMET01491 | |
| 0.019 | 0.278 | 0.049 | Lysine-specific demethylase 1A inhibitor | 0.049 0.048 DBMET01491 | DBMET01491 | |
| 0.102 | 0.364 | 0.489 | Antiobesity | 0.489 0.04 DBMET01491 | DBMET01491 | |
| 0.065 | 0.329 | 0.193 | Antipruritic | 0.193 0.054 DBMET01491 | DBMET01491 | |
| 0.007 | 0.273 | 0.066 | NMDA 2 receptor antagonist | 0.066 0.055 DBMET01491 | DBMET01491 | |
| 0.042 | 0.315 | 0.079 | Thioredoxin reductase inhibitor | 0.079 0.065 DBMET01491 | DBMET01491 | |
| 0.017 | 0.293 | 0.08 | NMDA receptor antagonist | 0.08 0.066 DBMET01491 | DBMET01491 | |
| 0.048 | 0.35 | 0.182 | Farnesoid X receptor antagonist | 0.182 0.028 DBMET01491 | DBMET01491 | |
| 0.004 | 0.306 | 0.044 | Adenosine A1 receptor agonist | 0.044 0.007 DBMET01491 | DBMET01491 | |
| 0.003 | 0.346 | 0.175 | Estrogen receptor beta agonist | 0.175 0.005 DBMET01491 | DBMET01491 | |
| 0.002 | 0.35 | 0.011 | Calcineurin inhibitor | 0.011 0.008 DBMET01491 | DBMET01491 | |
| 0.005 | 0.361 | 0.03 | Glucocorticoid antagonist | 0.03 0.024 DBMET01491 | DBMET01491 | |
| 0.078 | 0.44 | 0.151 | Catenin beta inhibitor | 0.151 0.104 DBMET01491 | DBMET01491 | |
| 0.003 | 0.38 | 0.141 | Estrogen receptor alpha agonist | 0.141 0.005 DBMET01491 | DBMET01491 | |
| 0.023 | 0.407 | 0.09 | Potassium channel large-conductance Ca-activated activator | 0.09 0.029 DBMET01491 | DBMET01491 | |
| 0.013 | 0.398 | 0.097 | CDC25A inhibitor | 0.097 0.029 DBMET01491 | DBMET01491 | |
| 0.006 | 0.416 | 0.046 | Opioid agonist | 0.046 0.045 DBMET01491 | DBMET01491 | |
| 0.065 | 0.486 | 0.141 | Papain-like protease (SARS coronavirus) inhibitor | 0.141 0.044 DBMET01491 | DBMET01491 | |
| 0.092 | 0.518 | 0.585 | Interleukin 2 agonist | 0.265 0.103 DBMET01486 0.265 0.103 DBMET01487 0.265 0.103 DBMET01488 0.265 0.103 DBMET01489 0.265 0.103 DBMET01490 0.585 0.004 DBMET01491 | DBMET01491 | |
| 0.011 | 0.456 | 0.08 | Analgesic, opioid | 0.08 0.047 DBMET01491 | DBMET01491 | |
| 0.025 | 0.514 | 0.24 | Estrogen antagonist | 0.24 0.009 DBMET01491 | DBMET01491 | |
| 0.02 | 0.514 | 0.076 | Opioid kappa receptor antagonist | 0.076 0.064 DBMET01491 | DBMET01491 | |
| 0.006 | 0.551 | 0.02 | Antibiotic Tetracycline-like | 0.02 0.004 DBMET01491 | DBMET01491 | |
| 0.015 | 0.563 | 0.077 | Factor IXa inhibitor | 0.077 0.017 DBMET01491 | DBMET01491 | |
| 0.044 | 0.604 | 0.326 | Growth hormone agonist | 0.326 0.027 DBMET01491 | DBMET01491 | |
| 0.012 | 0.581 | 0.165 | Estrogen receptor beta antagonist | 0.165 0.013 DBMET01491 | DBMET01491 | |
| 0.024 | 0.653 | 0.061 | Prolactin release inhibitor | 0.061 0.05 DBMET01491 | DBMET01491 | |
| 0.016 | 0.649 | 0.057 | Parathyroid hormone antagonist | 0.057 0.014 DBMET01491 | DBMET01491 | |
| 0.009 | 0.666 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.011 DBMET01491 | DBMET01491 | |
| 0.006 | 0.729 | 0.043 | Estrogen-related receptor beta antagonist | 0.043 0.009 DBMET01491 | DBMET01491 | |
| 0.012 | 0.789 | 0.113 | Vanilloid agonist | 0.113 0.022 DBMET01491 | DBMET01491 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |